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Abstract
Cys-loop receptors are pentameric ligand-gated ion channels (pLGIC), which play a 
crucial  role  in  rapid  neurotransmission.  They  are  the  targets  of  a  legion  of  drugs 
(antiemetics,  general  anesthetics,  benzodiazepines,  smoke  cessation  drugs,  etc.)  and 
their  physiological  properties  are  intensively  studied.  When  pLGICs  bind 
neurotransmitters,  they  undergo conformational  changes,  from a  resting  closed  pore 
state to a transient open pore state;  they can also enter a ligand-bound, closed pore, 
desensitized state. Moreover, the gating properties of pLGICs can be influenced by a 
variety  of  compounds (e.g.  lipids,  competitive  inhibitors,  allosteric  modulators,  ions 
such as  Ca2+),  which  makes  them flexible  receptors  capable  of  integrating  different 
signals into conformational changes.
In this thesis we focus on structural studies of the mouse serotonin type 3 receptor 
(m5-HT3R). The first  structure of the m5-HT3R, obtained by X-ray crystallography 
using stabilizing nanobodies, was a closed pore inhibited conformation (Hassaine et al.,  
2014).  As  a  follow  up,  we  aimed  to  obtain  structures  of  the  m5-HT3R  in  other 
conformations, in order to elucidate its gating mechanism. For this purpose we used 
both  X-ray  crystallography  and cryo-electron  microscopy  and thus  the  whole  thesis 
follows two story-lines. 
A general  introduction  of  the  pLGIC family  is  followed  by a  detailed  structural 
description of the m5-HT3R. In the results section, we present the optimized protocol 
for the receptor purification, we report that limiting diffraction is a bottleneck in the 
crystallographic  trials  and  we  emphasize  limits  met  using  nanobodies  for 
conformational stabilization of the receptor. In the electron microscopy results part we 
present the optimization of the sample and grid preparation that ultimately permitted 
data collection. We report four different structures representing distinct functional states 
of the m5-HT3R: an inhibited  tropisetron-bound closed conformation,  an open pore 
state and a putative pre-active state obtained in the presence of serotonin, and finally a 
closely-related putative pre-active state in the presence of serotonin and of the allosteric 
modulator  TMPPAA.  We  compare  our  data  with  structures  of  the  same  receptor 
obtained by other laboratory.
It was shown for the first time in our work how the antagonist (tropisetron) and the 
neurotransmitter  (serotonin)  bind  to  the  full-length  m5-HT3R.  And  our  structures 
deepen the knowledge of the receptor's gating mechanism.
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Résumé
Les  récepteurs  Cys-loop  sont  des  canaux  ioniques  pentamériques  activés  par  un 
ligand (pLGIC), qui jouent un rôle essentiel dans la neurotransmission rapide. Ils sont la 
cible de nombreuses familles de médicaments (antiémétiques, anesthésiques généraux, 
benzodiazépines,  médicaments  pour  arrêter  de  fumer,  etc.)  et  leurs  propriétés 
physiologiques  sont,  en  conséquent,  très  étudiées.  Lorsque  les  pLGIC  lient  des 
neurotransmetteurs,  ils  subissent  des  modifications  conformationnelles,  d’un  état  au 
repos où le pore est  fermé vers un état  transitoire  ouvert.  La liaison de ligand peut 
également  provoquer  un  état  conformationnel  fermé  et  désensibilisé.  En  outre,  les 
propriétés des pLGIC peuvent être influencées par divers composés (lipides, inhibiteurs 
compétitifs, modulateurs allostériques, ions tels que Ca2+), ce qui en fait des récepteurs 
capables d'intégrer différents signaux via des changements de conformation.
Dans cette thèse, nous nous concentrons sur des études structurales du récepteur de la 
sérotonine de type 3 chez la souris (m5-HT3R). La première structure du m5-HT3R, 
obtenue par cristallographie aux rayons X, représentait une conformation inhibée à pore 
fermé,  stabilisée  par  des  nanobodies  (Hassaine et  al.,  2014). Nous avons cherché  à 
obtenir  des  structures  dans  d’autres  conformations,  afin  d’élucider  son  mécanisme 
moléculaire  de  fonctionnement.  Pour  ce  faire,  nous  avons  utilisé  à  la  fois  la 
cristallographie aux rayons X et la cryo-microscopie électronique. Les résultats obtenus 
sont décrits dans 2 chapitres dédiés de la thèse.
Une  introduction  générale  de  la  famille  pLGIC  est  suivie  par  une  description 
détaillée  de la  structure  du m5-HT3R. Dans la  section  résultats,  nous présentons  le 
protocole optimisé pour la purification du récepteur, nous expliquons que la mauvaise 
diffraction est un facteur limitant dans les essais cristallographiques, et nous montrons 
les  freins  rencontrés  lors  de  l'utilisation  des  nanobodies  pour  la  stabilisation 
conformationnelle du récepteur. Dans les résultats de la microscopie électronique, nous 
présentons  l'optimisation  de  la  préparation  de  l'échantillon  et  de  la  grille  qui  a 
finalement permis la collecte de données. Nous décrivons quatre structures différentes 
représentant des états fonctionnels distincts du m5-HT3R : une conformation inhibée 
fermée liée  au Tropisétron  ;  un état  ouvert  et  un état  pré-actif  présumé obtenus  en 
présence de sérotonine ; et enfin un état proche de l’état pré-actif supposé, en présence 
de sérotonine et du modulateur allostérique TMPPAA. Nous comparons nos données 
avec les structures du même récepteur obtenues par un autre laboratoire.
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Notre travail a montré pour la première fois comment l'antagoniste (Tropisétron) et le 
neurotransmetteur  (sérotonine)  se lient  au m5-HT3R. Nos structures  approfondissent 
également la connaissance du mécanisme d’action du récepteur.
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Introduction
1 Introduction
When someone is searching for a job, her/his abilities to communicate represent one 
of the most  appreciated  skills by human resource recruiters.  In  biological  processes 
communication also plays a very important role.  Unicellular organisms developed  the 
ability  to  recognise  stimuli  coming  from  their  surroundings,  ways  to  process  the 
information, and signalling pathways which allow these stimuli to be acted upon (e.g. 
chemotaxis as a response to a chemical stimulus). Cells in multicellular organisms need 
to communicate  with each other to properly develop into different tissues  and organs, 
fulfil their desired role depending on the cell type, accommodate to external conditions 
and react to the requirements of the organism. The scope of this thesis is the structural 
study of  a  ligand-gated  ion  channel,  which  mediates crucial  communication,  which 
takes place in excitable cells.
As early as the  19th century, neurons were declared to be the functional building 
blocks  of  the  nervous system and  defined  to  be  independent  cells,  able  to  transfer 
directionally a signal from dendrite towards axones, and the Nobel prize was awarded to 
Santiago Ramón y Cajal and Camillo Golgi in 1906 for these discoveries. At that time, 
the  propagation  of  the  signal through neurons  was  not  well  understood.  The 
development of electrophysiology during the 20th century permitted the mechanism of 
signal propagation to be elucidated and emphasised the role of ion channels  in  this 
process,  Nobel  prize  in  Physiology  and  Medicine  awarded  to  Alan  Hodgkin  and 
Andrew Huxley in 1963. Our current  molecular  understanding of  how ion channels 
operate arises in part from the ability to obtain atomic structures by crystallography or 
cryo-electron microscopy since the turn of the millennium  (Doyle, 1998; Liao et al.,  
2013).
1.1 Action potential 
The neuronal  signal  transfer  is  divided into two stages:  I)  propagation  along the 
nerve cell  through  changes  in  the membrane potential  (electrical  signal)  and II)  the 
transmission of the signal at the neuron-neuron interface called the synapse, mediated 
by neurotransmitters (coupling). 
The  cytoplasmic  membrane  is  the  semi-permeable  hydrophobic  barrier  which 
encloses  all  living  cells.  While  small  hydrophobic  molecules  can  diffuse  across 
membranes,  charged molecules such as ions  cannot and thus they require specialised 
proteins  to  transport  them.  There  are  two  types  of  transport  across  the  membrane. 
15
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Active  transport  mediated  by  pumps  and  transporters  consumes  energy to  transport 
molecules  against  their  chemo-electrical  gradient.  Passive  transport  occurs  along  a 
gradient and is mediated by channels. 
 Concentrations  of  ions  differ  at  the  interior  and  exterior  side  of  the  plasma 
membrane.  In a typical  neuron, there are more Na+ ions outside than inside the  cell 
whereas the opposite is true for the K+ ions (Fig.  1).The general charge imbalance on 
different sides of membrane creates electrical field, negative inside, called membrane 
potential. Polarised neurons have a resting membrane potential of about -70 mV. This 
polarisation is maintained by sodium/potassium pumps and K+ channels. For two K+ 
pumped in 3 Na+ ions are pumped out of the nerve cell. If an excitatory stimulus reaches 
the  neuron in  the  resting  state,  this  results  in the  opening of  ion  channels  and the 
passage of sodium ions into the cell. If the stimulus is strong enough, the potential may 
reach  -55 mV and thus overcome a barrier  for an all-or-nothing phenomenon. At  this 
threshold, the change of the potential triggers the opening of voltage-gated ion channels, 
which mediate further depolarisation. This depolarisation  is then propagated along the 
neuronal body to the axon terminal - to the synapse. In synapses, the depolarisation 
opens calcium channels, yielding a flux of Ca2+ into the presynaptic terminal. The rise in 
presynaptic calcium concentration  triggers  the  fusion  of  intracellular  vesicles,  filled 
with neurotransmitters,  with  the  presynaptic  membrane  and the liberation  of 
neurotransmitters  into  the  synaptic  cleft.  Ligand-gated  ion  channels  located  in  the 
postsynaptic neuronal membrane bind these neurotransmitters, open and let  some ions 
pass  through  the  membrane  of  the  cell. This can  result  in  the  depolarisation  or 
hyperpolarisation (depending on the channel  selectivity) of  the new neuron and the 
message may eventually be transported through this new neuron as described above. 
16
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(Blaus, 2014)
1.2 The ion channels
Because  of  their  crucial  role  in  the  nervous  system the  ion  channels  have  been 
intensively studied more than 60 years (Hodgkin and Huxley, 1952). Together with the 
G-protein coupled receptors and kinases, the pore forming units of ion channels are 
amongst the most abundant genes in the human genome. Almost all ion channels are 
composed of  several  subunits and  form homomers  or  heteromers.  The existence  of 
different  heteromers  increases  the  number  of  the  variants  of  a  certain  type  of  ion 
channel  compared to  the  number of  different  subunits  encoded by  DNA sequences. 
Differences  between the subunits modify the channel properties and thus support their 
specialisation  and  plasticity.  Functional  channels  of  various  oligomeric  states  exist, 
from dimeric channels up to hexameric ones. Very often subunits are arranged around a 
central  pseudo-symmetrical axis  perpendicular  to the plane of the membrane,  which 
coincides with the pore (Fig. 2). 
17
Introduction
The ion channels do basically two things: they close or  open to let the ions pass 
through the highly hydrophobic core of the membrane. The channel stays in its open or 
closed state(s) several milliseconds, and the conformational change from the opened to 
closed  gates  occurs  in  the  order  of  a  hundred  times  per  second  with  the  flux  of
106-7 ions/s (Gadsby, 2009).  The ion channels are either strictly selective to the certain 
type of ions (e.g. K+ (Roux, 2017)) or they manifest promiscuity among either cations or 
anions (e.g. 5-HT3 channel among cations, Na+, K+, Ca2+ etc. and even some organic 
cations (Yang, 1990). We distinguish two classes of ion channels: the leaky and gated 
ion  channels.  Leaky  channels  show  constitutive  opening,  and  even  if  they  can  be 
regulated by external factors (e.g heat or mechanical stress for TREK channels), they do 
not directly  participate in rapid neurotransmission.  The determining characteristic  of 
gated  channels  is  their  ability  to  react  to different  stimuli  coming  from  their 
environment, and their rapid response. They all possess a “gate’’,  which is closed in the 
resting state and open only once the correct stimulus is  detected.  Depending on the 
signal  the channels recognise,  they  can  be  classified  into  further  subgroups. 
Voltage-gated ion channels, as the name suggests, react to changes of the membrane 
potential  and  this  group  comprises  for  example  of  the  K+,  Na+ and  also  the  Ca2+ 
channels.  Members  of  another  class  of  gated  ion  channels  respond  to  mechanical 
stimuli.  The  last  group  of  gated  channels  are  the  ligand-gated  ion  channels.  Their 
opening is dependent on the binding of a chemical compound. This last group comprises 
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of several  super-families: the  tetrameric  glutamate  receptors,  the  TRP channels,  the 
ATP-gated  ion  channels  and  the  Cys-loop  receptors.  The  Cys-loop  receptors  are 
pentameric ligand-gated ion channels and as the serotonin receptor of type 3 (5-HT3R), 
which is the focus of this thesis, belongs to this family, they are discussed in more detail 
in the following sections.
1.3 Discovery and characteristics of pLGIC
The mechanism behind the  chemo-electrical conversion  during  neurotransmission 
has been intensively studied since the beginning of the 20th century. The main limiting 
factors during that period were the available methods and the biological accessibility of 
the material studied. Key discoveries were made hand in hand with the development of 
the pharmacological, electrophysiological and biochemical methods.
Emil du Bois-Reymond, known as the father of electrophysiology, was able to detect 
electrical signals in frog muscle in 1843 and 4 years later, with an improved instrument,  
he was able to repeat his experiment in humans. In 1868 one of his followers, Julius 
Bernstein, measured the first action potential across the cellular membrane. In 1902 he 
formulated  the  membrane  theory  further  developed  by Howard  Curtis  and Kenneth 
Cole.  After  the proposition  of ion channel  existence  in 1952 by Alan Hodgkin and 
Andrew Huxley,  the  first  direct  observation  of  single  functioning  ion  channels  was 
obtained  in  the  1970s  by  the  “patch  clamp”  electrophysiology  method  invented  by 
Erwin Neher and Bert Sakmann. A breakthrough took place with the injection of brain 
extracted  mRNA  into  Xenopus  laevis oocytes,  leading  to  functional  ion  channel 
expression  at  the  cell  surface,  which  could  be  characterised  by  electrophysiology 
(Gurdon et al., 1971). This approach helped to overcome the fact that sequencing and 
cloning techniques were not available during that period and thus it was not possible to 
identify and overexpress the protein of interest. Those limiting factors were solved by 
two  biological  factors  in  the  case  of  the  nicotinic  acetylcholine  receptor  (nAChR), 
which made it the first pLGIC discovered and characterised. First,  cells of the electric 
organ  from  Electrophorus  electricus (Nachmansohn,  1959) were  shown  to  be 
extraordinarily rich in the acetylcholine neurotransmitter sensing receptors. This tissue 
provided sufficient amounts of working material but it was only of low specificity. The 
second biological factor that helped to identify the sensing unit was the discovery of a 
snake  venom  component,  the  alpha-bungarotoxin  (Chang  and  Lee,  1963),  which 
specifically binds to  the  nAChR receptor  and  was  shown  to  be  a blocker  of 
neurotransmission. A close homologue of this toxin, linked to Sepharose beads, served 
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as the first tool for the affinity purification of receptors.  This breakthrough helped to 
clarify that it is the nAChR and not the acetylcholinesterase that interacts with the toxin. 
The nAChR was determined to be the bearer of the neurotransmitter response.
In  parallel  with  the  advancements  being  made  on  the  nAChR,  the  inhibitory 
neurotransmitters glycine and γ-aminobutyric acid (GABA) were used to identify their 
receptors, which were both purified in 1982  (Pfeiffer et al., 1982; Stephenson et al.,  
1982).  Only  five  years  later  the  DNA  regions  encoding these  two  receptors  were 
sequenced  (Grenningloh  et  al.,  1987;  Schofield  et  al.,  1987) and shown  to  be 
homologous to the nAChR. The Cys-loop receptor family was further enlarged with the 
cloning, expression and characterisation of  the 5-HT3R (Maricq et al., 1991) and the 
invertebrate glutamate-gated chloride channels (GluCl) (Cully et al., 1994). Prokaryotic 
homologues were also identified  using sequence analysis  (Tasneem et al., 2005). Two 
of  them,  originating  from  Gloeobacter  violaceus (proton-gated  GLIC receptor)  and 
Erwinia chrysanthemi (GABA-gated ELIC receptor) have been extensively studied in 
structure-function projects  aimed at  understanding gating and transitions.  These two 
receptors lack the characteristic Cys-loop and thus the alternative name  - pentameric 
ligand-gated ion channels can be considered as more precise. All receptors from this 
family  share a similar architecture  but the prokaryotic receptors  lack the intracellular 
domain (ICD).
The  pentameric  ligand-gated  ion  channels  are  classified  according  to  their  ion 
selectivity. The nAChRs and  5-HT3Rs are cation-selective channels, so movement of 
ions through them causes  a depolarisation  of the membrane (excitatory postsynaptic 
potential).  Conversely, the  glycine  receptor  (GlyR)  and  the  GABAA  receptors 
(GABAAR) are anion-selective channels and movement of ions through them leads to a 
hyperpolarisation (inhibitory  postsynaptic  potential).  Both  prokaryotic  homologues 
GLIC and ELIC are cation selective.
The variety of the genetically encoded subunits and the ability of the cell to compose 
pentamers composed of diverse subunits adds to the overall functional plasticity and 
physiological  properties  of  the  receptors.  The  human  genome  codes  for  about  19 
different  subunits  of  GABAAR  and  for  17  different  subunits  of  nAChR.  Smaller 
diversity is observed for the GlyR represented by only 5 different subunits as well as for 
the  5-HT3R  where  the  five  different  subunits  carry  the  names  from  A-E.  The 
phylogenetic  relationships  between the  different  subunits  of  each  receptor  class  are 
shown in (Fig. 3).
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Generally the working  mechanism of all the Cys-loop receptors is the same. They 
open transiently when an agonist binds but after longer  exposure to the agonist they 
switch into the stimuli ignoring state during which the cellular response decreases. This 
state is called the desensitised state and ions are not able to pass through the channel in 
this  state.  After the washout of the agonist  the receptor  returns into its  resting state 
directly, without the need for reopening. This entire process was first described for the 
nAChR  (Katz and Thesleff, 1957). Since then, its binding specificity and the binding 
kinetics have been further studied. It is clear now that a variety of molecules might 
interact with and dissociate from the receptor with different kinetics, which is further 
influenced  by  allostery  and  that  this  process  might  be  dependent  on  the  receptor 
conformational state (Monod et al., 1965).
The Cys-loop receptors are implicated in multiple diseases, for example  in anxiety, 
epilepsy  and  Alzheimer's  disease.  They  are  targets  of  clinically  used  anaesthetics, 
anti-emetics, barbiturates, steroids and on the biological level also of toxins, alcohol and 
nicotine  (Connolly  and Wafford,  2004; Lester,  2004; Thompson et  al.,  2010).  I  will 
focus on the detailed functional  properties of the 5-HT3R and its  structural  features 
compared to the other Cys-loop receptors in the following sections. 
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1.4 The 5-HT3 receptor. Discovery, composition, physiological 
properties and pharmacology
5-hydroxytryptamine (5-HT)  or  serotonin is  the  neurotransmitter  biochemically 
derived from tryptophan.  It  is  mostly produced in the enterochromaffin  cells  of the 
gastrointestinal tract  but  it  is  also  present  in  the  serotonergic  nerves  in  the  central 
nervous system (CNS).  There are  seven classes of receptors  sensing serotonin  - the 
serotonin receptors. The 5-HT3R is the only ion channel out of the 7 different classes of 
serotonin receptors. The rest of the serotonin receptors are G protein-coupled receptors 
and they influence physiological processes such as sleep, memory, learning, respiration, 
mood, anxiety, locomotion and more (the overview of the G-protein coupled serotonin 
receptors can be found in the review of Pytliak et al.( 2011)). 
The initial discovery of the 5-HT3 receptor is linked to the determination of the two 
pharmacologically distinct types of serotonin receptors. The “D” type receptors, which 
can be inhibited by dibenzyline, mediate the contraction of smooth muscle and the “M” 
type, which can be inhibited by morphine, cause the depolarisation of the cholinergic 
neurons in the guinea-pig ileum (Gaddum and Picarelli, 1957). When the classification 
and the unique nomenclature was established the “M” type serotonin receptors became 
the 5-HT3 receptors  (Bradley et al., 1986) and were further characterised as we know 
them today (Maricq et al., 1991). 
5-HT3Rs are located in the peripheral nervous system (PNS) as well as in the CNS 
(Tecott et al., 1993) both, pre- and post-synaptically. The presence of the 5-HT3R was 
proven  in  the  peripheral  preparations  of  myenteric  plexus  (Mawe  et  al.,  1986), 
submucous  plexus  (Derkach  et  al.,  1989),  nodose  ganglion  (Higashi  and  Nishi,  
1982) and  vagus  nerve  (Azami  et  al.,  1985).  After  its  localisation  to  the PNS,  its 
existence was also proven in the CNS by mapping of the 5-HT3R activity in the rat 
brain (Kilpatrick et al., 1987). In the CNS, 5-HT3R is localised to the hippocampus, the 
amygdala, the area postrema and the nucleus tractus solitarius  (Koyama et al., 2017; 
Miquel et al., 2002)  (Fig. 4).
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Five subunits A-E of the 5-HT3R have been identified to date. The A subunit was 
followed by the B subunit  discovery and expression four years later  (Davies  et  al.,  
1999).  Three  more  putative  5-HT3R-encoding  genes  HTR3C,  HTR3D and  HTR3E 
were found in the human brain coding for the C-E subunits (Niesler et al., 2003). Some 
of the subunits exist in  a variety of isoforms. The 5-HT3R A subunit (5-HT3RA) has 
short and long splice variants differing by 32 amino acids, and other post translational 
variants  are  also  known  for  the  5-HT3R  B  (5-HT3RB)  and  E  subunits.  The 
homopentamer receptors can be made only of A subunits (Davies et al., 1999). None of 
the subunits B-E forms functional homopentamers and moreover the heteropentamers 
require the presence of at least  one A subunit.  The functional  properties of the C-E 
subunits and their presence across species is discussed in detail in the work of Holbrook 
and co-workers (Holbrook et al., 2009) and that of Niesler and co-workers (Niesler et  
al., 2007). The rodents genome codes only for the A and B subunits and interestingly, 
they never vomit. The absence of the other subunits as a reason of the phenotype is 
tempting but remains speculative.
The general architecture of all the different subunits is identical. They are composed 
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of  the  extracellular  domain  (ECD)  formed  mostly  by  beta-sheets.  They  have  four 
transmembrane helices. Only helix 2 (M2) is the pore forming helix and the rest of the 
helices protect it from contact with the lipid bilayer. The M3 helix is connected to the 
M4 helix by the long M3-M4 loop. C-terminal to the M3 there is a peri-membrane short 
helix  (MX)  and  then  the  unstructured  longer  loop  connects  the  MX  helix  to  the 
cytoplasmic prolongation of the membrane helix 4 (M4) called the MA helix (Fig.  5). 
The  binding  site  of  the  receptor  is  formed  by  the  contact  of  the  two  consecutive 
subunits. The detailed view of the structural features of the 5-HT3 receptors will be 
provided in section 1.5.2.
1.4.1 Functional properties
The early electrophysiological studies were performed on isolated tissues or on cells 
expressing the 5-HT3R naturally (Hussy et al., 1994). Only after the successful isolation 
of the gene coding for the A subunit were the homopentamers studied in oocytes (van 
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Hooft  et  al.,  1997).  The  single  channel  conductance  of  native  5-HT3Rs was tissue 
dependent and ranged between 9 and 17 pS (Fletcher and Barnes, 1998), whereas it was 
only  in  the  sub-pS  range  for  5-HT3A homopentamers  expressed  in  a  heterologous 
system (Gill et al., 1995). This suggested that multiple forms of the receptor might be 
present. At first, splice variants of the A subunits were hypothesised to be a source of 
the heterogeneity but it was shown that the presence variants had only a minor impact 
on the pharmacological and functional properties of the receptor (Hope et al., 1993). In 
the end, it was a direct comparison between the heterologously expressed 5-HT3RA and 
the  native  receptors  of the  superior  cervical  ganglion  neurons,  which provided  the 
evidence  for  multiple  channel  forms.  Although the  pharmacological  properties  were 
nearly  identical, the conductance of the heterologously expressed receptors was about 
0.4-0.6 pS compared to the 9 pS conductivity  of  the native receptors  (Hussy et  al.,  
1994).  Furthermore,  the  whole-cell  noise  analysis  of  the  mureine  superior  cervical 
ganglion  neuron receptor  revealed  the  single-channel  conductance  of  3.4  pS.  This 
suggested a co-existence between 9 pS conductance channels and channels with a lower 
conductance. It implied the presence of at least two different forms of the receptors. The 
B subunit was discovered and shown to be unable to form a functional homopentamer. 
The conductivity  of the A-B heteromers  fitted well  with the data obtained from the 
measurements  carried out with the 5-HT3Rs expressed natively  (Davies et al., 1999) 
(Fig. 6).
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To further explain the effect of the B subunit on the conductance, chimeric receptors 
swapping domains between the A and B subunits were created (Kelley et al., 2003). The 
conductivity-determining  region was shown to  be  in  the  cytoplasmic  portion  of  the 
receptor.  The  alignment  of  the  sequences  of  the  A  and  B  subunits  from  different 
organisms revealed three highly conserved arginine residues (R416, R420, R424) within 
the cytoplasmic region of the A subunit. When these were mutated to the corresponding 
residues of the B subunit (R416Q, R420D and R424A) and co-expressed with the WT A 
subunit, the conductivity increased. Importantly, this conductivity corresponded to the 
one  observed  in  tissues  expressing  the  A/B  heteromers  natively.  Initially,  it  was 
believed that the positive charge of these residues  was the main determinant of their 
role: they would essentially lower the flux of cations exiting the receptor through lateral 
portals (Kelley et al., 2003). Later on, based on the structural prediction of the MA helix 
and on site directed mutagenesis, it was shown that putative salt bridges could be more 
important  than the  actual  presence  of  the  charge  (Kozuska  et  al.,  2014).  This was 
demonstrated by a study where acid residues E414, E418 and D425 were mutated to 
their amide counterpart (QQN) to break salt bridges made with the other residues. The 
conductivity of this triple mutant was comparable to that of  the initial RRR to QDA 
mutation  and moreover  the  single  mutant  E418Q also presented  a  big conductance. 
General  suggestion  that  the charged residues  in  the intracellular  domain might  play 
stabilising roles being involved in salt bridges was further supported by mutagenesis of 
the other charged residues preceding E418. 
The RRR residues line the portals  of the cytoplasmic  vestibule and it  was under 
question whether they determine only the conductance of the receptor or if they also 
participate in size selectivity towards the permeant ion. By analysis of the ion selectivity 
of the 5-HT3R mutants missing the M3-M4 loop compared to the selectivity of the WT 
receptor, it was shown that the RRR triplet is not essential for ion selection (McKinnon 
et al., 2011).
The  channel  selectivity  filter  was determined  based  on  the  mutagenesis  of  the 
5-HT3R residues analogous to those influencing the ion selectivity properties of the 
other  Cys-loop  receptors  (Gunthorpe  and  Lummis,  2001).  The  alignment  of 
anion-selective and cation-selective Cys-loop receptors revealed the conserved presence 
of  positively  or  negatively  charged  residues  corresponding  to  the  anion- and 
cation-selectivity,  respectively.  These  rings  are  located  on  the  extracellular  and 
intracellular  ends  of  the  pore.  Based on mutagenesis  studies  results,  the  lower  ring 
formed by E250  on the  intracellular  side  seems to  be  the main  determinant  of  the 
5-HT3R  selectivity  (Thompson  and  Lummis,  2003).  The  5-HT3R  is  relatively 
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promiscuous with regard to its selectivity. The selectivity among different cations was 
predicted based on the property to reverse near 0 mV, suggesting similar permeabilities 
for Na+ and K+ cations. The 5-HT3R discriminates between the small monovalent ions 
(Cs+,  K+,  Li+  < Na+  = Rb+)  only weakly  (Yang, 1990).  Moreover,  even some of the 
organic cations (e.g., ammonium and methylamine) are able to pass through the channel 
and unsurprisingly their permeability decreases with their increasing size (Yang, 1990). 
The divalent  cations (Ca2+,  Ba2+,  Mg2+) also pass through the selectivity  filter  of the 
5-HT3R. The calcium permeability of the receptor varies between the splice variants of 
the  5-HT3R  A  subunit,  with  the  shorter  variant  enabling  higher  permeability 
(Hargreaves et al.,  1994).  Moreover, the  presence of divalent cations modulates the 
amplitude of the signal and also the duration of the response to the agonist (Thompson 
and Lummis, 2009). The absence of calcium cations increases both of these factors. The 
Ca2+ inward flux  into presynaptic  terminals results in exocytosis  (Rondé and Nichols,  
1998).  As the presynaptic 5-HT3 receptors were shown to mediate GABA release  in 
proportion to  the Ca2+ concentration  (Turner et al., 2004), it  has been speculated that 
Ca2+ permeability was more relevant to presynaptic physiology than to postsynaptic Ca2+ 
uptake.
1.4.2 Pharmacology
The 5-HT3Rs are proposed to play a role in the development of multiple diseases and 
psychological disorders (Fakhfouri et al., 2019; Gupta et al., 2016). They are the main 
pharmacological  target of  drugs  marketed  for irritable  bowel  syndrome  (Tyers  and 
Freeman, 1992) and chemotherapy induced nausea and vomiting (CINV), as well as for 
post-operative  nausea  and  vomiting (Humphrey  et  al.,  1999).  In  both  of  the 
aforementioned cases the active drugs are antagonists from the ¨setron¨ family (Fig. 7). 
CINV is one of the most dreaded effects of chemotherapy  (Coates et al., 1983). It 
causes discomfort and negatively influences adherence to the chemotherapy treatment 
regime (Bloechl-Daum et al., 2006). Since their discovery in the 1980s, antagonists of 
5-HT3R are used and have been further developed as the most potent drugs for the 
treatment  of  CINV  (Sanger  and Andrews,  2018).  Currently,  together  with  the  NK1 
inhibitors and with steroids, they form the three drug CINV treatment regimen (Gilmore 
et al., 2018). There is a tendency to create universal guidelines for CINV prophylaxis 
but  all  attempts  are  complicated  by  a  lack  of  understanding  of  the  underlying 
pathophysiology and by the subjectivity of nausea assessment by patients.
Some of the drugs  targeting the 5-HT3R such as ondansetron and clozapine have 
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been shown to have a positive effect on schizophrenic symptoms (Meltzer et al., 2003). 
Furthermore, mutations in the 5-HT3R were observed in the genomes of patients with 
bipolar disease  and schizophrenia but their impact on pathology has not been directly 
proven  (Niesler  et  al.,  2001).  Although further  clinical  tests  are  needed it  has been 
concluded that the 5-HT3R antagonists are involved in the treatment of the depression 
(Hewlett  et  al.,  2003).  Indeed,  the recently marketed  Vortioxetine  antidepressant,  in 
addition to its known effects on the serotonin transporter and the 5-HT1 receptors, also 
potently inhibits the 5-HT3R. However, the role of 5-HT3R inhibition in the clinical 
effect of Vortioxetine remains undetermined, even if the marketing of the drug insists 
on  its  “multimodality”  (Katona  and  Katona,  2014).  Substance  abuse  and  addiction 
studied  in  mice  determined  that  the  5-HT3R  is  involved  in  self-administration  of 
ethanol  and  for  cocaine  sensitisation  (Hodge  et  al.,  2004,  2008). Importantly, 
self-administration of ethanol was also shown to be reduced by 5-HT3R antagonists in 
humans (Johnson et al., 2002). The 5-HT3R also reacts to anaesthetics from different 
families including inhalation and intravenous anaesthetics, as well as local anaesthetics 
(Barann et al., 2008; Stevens et al., 2005; Urban et al., 2006).
Amongst natural compounds acting on the 5-HT3R, morphine (the opioid analgesic 
from  unripe  poppy  seeds)  (Gaddum  and  Picarelli,  1957),  alpha-thujone  (the 
psychotropic  component  of absinthe from wormwood)  (Deiml et  al.,  2004),  and the 
gingerols and shogaols (the antiemetic compound from the ginger extracts) (Abdel-Aziz  
et al., 2006) can be mentioned.
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1.5 The 5-HT3R structure and its comparison to other known 
structures of Cys-loop receptors. 
Efforts to elucidate the structure of the Cys-loop receptors began with the soluble 
acetylcholine binding protein, a marine snail protein homologous to the extracellular 
domain of the Cys-loop receptors. Its X-ray structure was solved in 2001 (Brejc et al.,  
2001) and unveiled  the  architecture  of  the  extracellular  domain  of  pLGIC and  the 
organization of the orthosteric binding site. The first structure of a full length Cys-loop 
receptor  was  the  cryo-electron  microscopy  (cryo-EM) structure  of  the  heteromeric 
nicotinic acetylcholine receptor extracted from the  Torpedo marmorata electric  tissue 
(Miyazawa et al., 2003; Unwin, 2005).  It permitted to understand the receptor global 
architecture and provided a first structural framework to interpret the accumulated body 
of  functional  data  on  pLGIC.  However  the  resolution  remained  limited.  As  a 
consequence, the register of the amino acid assignment of this structure was later shown 
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to be out by ~1 helix turn beginning with the M1/M2 loop when compared to newly 
published structures  (Hibbs and Gouaux, 2011). The first  full-length structures to be 
solved by crystallography  were of that of pentameric ligand-gated ion channels from 
prokaryotic organisms, ELIC from Erwinia chrysanthemi (Hilf and Dutzler, 2008) and 
GLIC from  Gloeobacter  violaceus (Bocquet  et  al.,  2008),  hypothesised to  be in the 
closed and the open conformation, respectively. Interestingly, neither ELIC nor GLIC 
possess intracellular domains: they lack the MX helix, the long unstructured loop, and 
the MA cytoplasmic helix. Thus, their subunits are composed only of the ECD and the 4 
membrane helices connected by shorter loops. These structures were followed by the 
first  eukaryotic  structure  of  the  Caenorhabditis  elegans  glutamate-gated  chloride 
channel α, the GluCl channel,  where the natural intracellular domain was replaced by 
the  short  linker  M3-Ala-Gly-Thr-M4 (Hibbs  and  Gouaux,  2011). In  that case, 
stabilising  antigen-binding  fragments  (Fab)  proteins  were  used  as  crystallization 
chaperones to enhance the pentamer stability and also to help with crystal contacts. In 
2014, the structures of the first two mammalian Cys-loop receptors were  obtained by 
X-ray crystallography. These were those of the homomeric GABAA receptor composed 
of β3 subunits, and with its intracellular domain removed (replaced by the SQPARAA 
amino  acid  sequence)  (Miller  and  Aricescu,  2014) and  of  the  m5-HT3RA, which 
included the structured parts of the intracellular domain, the MX and the MA helices 
(Hassaine  et  al.,  2014).  The  latter  was  obtained  in  the  presence  of  stabilising 
nanobodies. The GABAA receptor was supposed to be in the desensitised state and the 
5-HT3R  was speculated to be in the closed conformation based on the fact that the 
stabilising nanobody used in the structure is actually acting as an antagonist. Structures 
of the homomeric glycine receptor in the open, desensitised and closed conformations, 
obtained  by  cryo-electron  microscopy,  enabled  direct  comparison  of  the  different 
conformational states  (Du et al., 2015). The constructs used for that study lacked the 
intracellular domain, which was replaced by M3-Ala-Gly-Thr-M4. At the same time the 
X-ray structure of the GlyRα3 was solved, with a resolution up to 3 Å, in the presence 
of the antagonist  strychnine  (Huang et  al.,  2015). As in most cases, its  intracellular 
domain was absent and the  receptor is supposed to be in the antagonist-bound closed 
conformation. The only known heteromeric structures to date belong to the nAChR and 
GABAA family.  Thirteen years after the low resolution  EM structure  of the  Torpedo 
nAChR, the X-ray structure of the recombinant  2α:3β nAChR α4β2 was solved. The 
structure  was obtained in  the  presence of  nicotine  bound to the  binding site  and is 
believed to be in the desensitised conformation. 
After  the crystallographic  structure  of  2α:3β nAChR α4β2,  the stoichiometrically 
distinct nAChR α4β2 3α:2β was solved by cryo-EM (Walsh et al., 2018). This enabled a 
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direct  comparison between different  assemblies  and elucidated  the  principles  of  the 
subunit  packing  mechanism.  The  cryo-EM  structure  of  the  5-HT3R without  ligand 
(Basak et al., 2018a) revealed only minor differences between the potentially inhibited 
receptor solved in the presence of VHHs and the apo structure. Two conformationally 
distinct structures of the GABAA α1β2γ2 receptor (Zhu et al., 2018) and one additional 
structure  of  GABAA  α1β1γ2  (Phulera  et  al.,  2018) were  recently  solved,  all  by 
cryo-EM,  showing  the  organisation  of  consecutive  subunits,  revealing  the  ECD 
vestibule glycosylations and more importantly illuminating the mode of ligand binding. 
Interestingly, GABAA α1β1γ2 structure revealed the asymmetry of the TMD subunit 
organisation  around  the  pore  axis  and  the  GABAA  α1β2γ2  structure  showed  the 
complete  gamma  subunit  collapse  into  the  TMD  pore.  In  contrast  to  those  two 
structures, the GABAA α1β3γ2 structures (Laverty et al., 2019; Masiulis et al., 2019), 
solved by cryo-EM as well, presented the symmetrical organisation corresponding to 
that of the homopentameric GABAA β3 solved by X-ray crystallography. The potential 
source  of  dissimilarities  might  be  a  use  of  detergents  and  engineered  constructs 
(deletion of ICD) in the case of distorted structures in contrast to the use of nanodiscs 
and full length construct for the symetricaly organised GABAA α1β3γ2 structures. The 
X-ray  structure  of  the  chimeric  ELIC(ECD)  - GABAA  α1(TMD)  indicates  the 
differences  between  the  apo  and  alphaxalone-bound  chimeric  receptor  which  is 
supposed to be desensitised (Chen et al., 2018). Finally our recent structural study of the 
5-HT3RA receptor mapped the changes that occur during the activation of the receptor 
by serotonin. These conclusions are supported by the comparison of the apo (Basak et  
al., 2018a), two open pore structures , two agonist-bound closed pore states (Basak et  
al., 2018b; Polovinkin et al., 2018) and one pre-active state (Polovinkin et al., 2018). A 
simplified overview of the pLGIC structures solved up to 2018 is summarised in Fig. 8 
and  for  the  sake  of  completeness  table  with  structures  of  pLGIC  can  be  found  in 
supplementary data Tab. 1.
The non-physiological membrane domain environment (mostly detergent until last 
year,  and  now  also  nanodiscs)  together  with  the  experimental  conditions  (crystal 
packing  or  freezing)  often  raises  questions  about  the  correlation  of  structures  with 
physiological  conformations  existing in the cell  membrane.  Moreover,  regarding the 
Cys-loop receptors,  the functional  assignments of the captured conformational  states 
might be strenuous. Still the comparison of multiple steady-state structures of the same 
protein is probably the best tool we have at the moment to understand the molecular 
mechanism of operation. As with GlyR, more and more receptors are being solved in 
different  conformations  and  stoichiometries,  permitting  us  to  better  understand  this 
family.
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1.5.1 The overall structure
The 5-HT3R is composed of five subunits arranged in a pseudo-symmetrical manner 
around the axis formed by the ion permeation pathway. The ECDs are formed by  β 
sheets forming a β-sandwich. Each β-sandwich overlaps with the consecutive one on the 
outer  side  of  the  receptor in  a  counter-clockwise  manner.  On  the  interface  of  two 
consecutive ECDs the overlap of the main subunit, the (+) side of the binding pocket, 
and the complementary subunit, the (-) side of the binding site, create the orthosteric 
binding site for the neurotransmitter (Fig. 9). The ECDs form multiple contacts with the 
membrane helices through the loops, which allows signal to be propagated from the 
bound  neurotransmitter  to  the  membrane  portion  of  the  receptor  (Fig.  10).  The 
membrane helices are organised in concentric rings. The innermost ring is formed by 
the M2 helices of each subunit which line the pore. These are enclosed by the middle 
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ring, composed of the M1 and M3 helices, and the M4 
helices form the peripheral ring (Fig. 11). The position 
of the M4 helix provides it with  a large surface with 
which to interact with the lipid environment. The MX 
helices  are  positioned  at  the  outer  side  of  the  M4 
helices, reminiscent of clamps that may keep the entire 
membrane portion together and  may stabilize the M4 
position. There is no structural information about the 
unstructured part of the M3-M4 loop. The continuation 
of the M4 helices protruding into the cytoplasm, the 
MA  helices,  are  slightly  twisted  counter-clockwise 
relative to the ion permeation axis. The M4 ends at the 
extracellular  side,  determining  the  topology  of  the 
protein  whereby both  C- and N- termini  are  located 
outside of the cell.
1.5.2 Detailed structural features
1.5.2.1 Extracellular domain -  neurotransmitter binding site
For the Cys-loop receptors, the neurotransmitter binding site was elucidated by the 
use of the homology,  comparing  the Cys-loop receptor  ECD to the structure of  the 
AChBP  (Brejc et al., 2001). The ECD β-sandwiches are formed by the 10 β-strands 
divided into two main β-sheets. The binding site is formed by “loops” A, B and C from 
the principal subunit and “loops” D, E, F and G from the complementary subunits (Nys 
et al., 2013) (Fig.  9A). It is  worth noting that the term “loops” is not strictly correct, 
because not all of these elements are actually loops. Structurally,  only the following 
elements corresponds to loops: loop A connecting β-strand 4 to β-strand 5 (β4-β5 loop), 
loop C (β9-β10 loop) and loop F (β8-β9 loop). ¨Loops¨ E, D and G are actually portions 
of β-strands. Residues that participate  in ligand binding in the orthosteric binding site 
come from “loop” B and are located partially on the β7 strand and partially on the β7-β8 
loop. Some of the features of this binding site are well conserved among the Cys-loop 
receptors, even though their ligands vary. There is a conserved “aromatic box” within 
the  majority  of  the  Cys-loop  receptors,  located  on  the  interface  of  some  of  these 
conserved elements (Lester, 2004). In the 5-HT3R, the “aromatic box” is defined by 
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aromatic residues W156, Y207, W63, Y126 and F199 from loops B, C, D, E and F, 
respectively. Some of the binding site residues are conserved across all of the different 
types  of  Cys-loop  receptors  as  seen  on  the  sequence  alignment  in  (Fig.  9B). The 
observation  that  the  loop  C  is  generally more  open  in  the  case  of  the 
antagonist-bound/closed or resting/closed state, and moves closer to the binding site if 
an  agonist  is  present  and  induces  the  agonist-bound/open  conformation  or  the 
agonist-bound desensitised/pore closed state, was extrapolated from AChBP to pLGIC. 
Thus the  loop C was commonly used to be a  criterion for the determination of the 
overall receptor functional state. The ligand-bound structures of the pLGIC generally 
manifest  described C loop movement,  but it  might  be very subtle and allows rather 
comparison of two structures than the interpretation of the structural state by itself. The 
subunit-subunit rearrangement is a better guideline to the functional state determination 
(Hassaine et  al.,  2014). The structure of the 5-HT3RA was solved using the VHH15 
nanobody, which binds to the subunit interface from the outside of the binding pocket 
and actually grasps loop C, bending it towards the outside. 
Insights into ligand binding  to the 5-HT3R were obtained by comparison with the 
AChBP solved in the presence of ligands. Mutagenesis of the AChBP binding site to 
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mimic the 5-HT3R binding site led to the creation of the model protein 5-HTBP, which 
has the binding properties of the 5-HT3R (Kesters et al., 2012; Price et al., 2016).
Based  on  functional  studies  of  the  5-HT3R binding  site  mutants,  the  impact  of 
different amino acids on ligand binding was proposed  (Beene et al., 2002; Spier and  
Lummis, 2000; Thompson et al., 2005). The majority of the binding studies were done 
with  antagonists  of  the  receptor  from  the  “setron”  family,  mostly  tropisetron  and 
granisetron. The π electrons from the aromatic residues are supposed to interact with the 
cation  provided  by  the  positively-charged  ring-embedded  nitrogen  what  was 
hypothesised for both, agonists (Spier and Lummis, 2000) and “setron” antagonists. The 
orientation of the ligands within the binding site was speculative and controversial. Yan 
and White (Yan and White, 2005) proposed that the granisetron orients its bicyclic ring 
to interact with residue W63.  Mutagenesis to introduce unnatural amino acids at this 
position  suggested  a different  interaction  mode  between granisetron  and  the  W63 
position, showing that the cation-π interaction might actually occur via W156 (Duffy et  
al., 2012). Recently,  the binding properties of granisetron and tropisetron, which are 
closely related, were discussed. Even though the structures of the AChBP solved in the 
presence of these ligands  implies they are orientated in the same way, the extensive 
mutagenesis of the 5-HT3R binding site and the binding studies of the two agonists 
implied  different  properties,  suggesting  that  these  two  ligands  might  interact 
differentially with the 5-HT3R binding site (Ruepp et al., 2017). Moreover, the binding 
orientations  based on functional  studies  and modelling,  were proposed by the  same 
study. 
A very recent structures of the tropisetron bound (see the results presented in section 
5.2.2) and granisetron bound m5-HT3R (Basak et al., 2019) confirmed the orientation 
of the ligand in the binding pocket; the amin-carrying bicyclic ring points outwards and 
the indazole ring mediates the cation-π interaction deeper in the binding pocket.
1.5.2.2 ECD-TMD interface -  binding signal transduction
pLGICs can possess several orthosteric binding sites (5 in the case of the 5-HT3RA) 
where the binding of a ligand can trigger the channel opening. Conformational changes 
are  often  described  either  as  of  a  ligand-induced  selection  from  the  pre-existing 
conformational states (Monod-Wyman-Changeux model, MWC) or as ligand-induced 
sequential  conformational  changes  (induced  fit  model,  IF).  According  to  the  MWC 
model all subunits of the existing populations of receptor are in the same conformation 
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and the switch of equilibrium induces the concerted change of all the subunits at once. 
In contrast, IF model predicts that the binding of ligand changes the  conformation of 
influenced subunits, what increases the binding affinity of the following ligand up to the 
complete  rearrangement  of  all  subunits.  In  a  way  the  MWC  model  describes  the 
conformational changes rather at the quaternary structure level and the IF model rather 
at  the  tertiary  structure.  The  following  paragraphs  aim  to  point  to  the  structurally 
important  and  interacting  elements  (residues,  secondary,  tertiary  and  quaternary 
structures) regardless the ligand-induced cooperativity scheme they follow.
Considering the available structural knowledge of the Cys-loop receptors, a relevant 
description of the mechanism of signal transduction probably comes from a comparison 
of the multiple conformations of the GlyR solved by EM (Du et al., 2015). This series 
of structures  permits a direct comparison of the interface between the ECD and the 
TMD among different conformational states within one receptor type. Starting with the 
binding  of  a ligand  in  the  binding  pocket,  the  C-loop  moves  outwards when  an 
antagonist  is  bound or  moves inward (towards  the binding site)  when an agonist  is 
present. When we consider only the principal (+) subunit , the binding signal might be 
transduced  through  movements  of  the  β9  and  β10  strands,  thus  influencing  the 
conformation of loop β8-β9 (F loop) and of the β10/pre-M1 loop region (Fig. 10) at the 
ECD-TMD interface.
Conformational changes affecting the M1 helix can directly influence the position of 
the M2 helix. Moreover, the β10/pre-M1 loop region is in contact with the Cys-loop, 
which  in turn interacts  with   the β1-β2 loop and, most importantly,with  the M2-M3 
loop. The M2-M3 loop can then directly influence the conformation of  the M2 helix. 
This is also the place where two neighboring subunits meet each other at the ECD-TMD 
interface. The M2-M3 loop from the (+) subunit interacts with the β8-β9 loop (F loop) 
and the β10/pre-M1 loop from the neighbouring (-) subuni. In the article reporting the 
GlyR structures, a direct link between M2 helix rotation and the position of the ECD 
was described in detail, highlighting residues that play a role in this process (Du et al.,  
2015). The tip of the Cys-loop, which plays the central role in the signal transduction, is 
very well  conserved among the family.  The 142-F/YPXD-145 motif  in  particular  is 
found in  all  the  receptors  of  the  family.  Another  conserved  residue is  the  arginine 
located at position 218 in the m5-HT3RA. R218, reported to be responsible for changes 
in gating properties after  ligand binding  (Hu et al.,  2003) is the key interactor with 
multiple elements on the ECD-TMD interface. It is sandwiched from the top and bottom 
by  the  two  aromatic  residues  W187  of  the  β8-β9  loop  (F  loop)  and  F142  of  the 
Cys-loop.  Moreover,  R218 is  enclosed  by  multiple  negatively  charged  residues, 
specifically by D145 of the Cys-loop from one side, by E186 of the β8-β9 loop (F loop) 
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from the other side, and by E53 located on the β1-β2 loop from the front (Hassaine et  
al.,  2014). Unfortunately,  the tip of the M2-M3 loop is not resolved in the 5-HT3R 
structure and thus hinders the assignment of the interactions of the 4 missing TAIG 
residues. There is actually an alanine insertion in the mouse construct used in structural 
studies from our laboratory, mimicking the human M2-M3 loop. 
1.5.2.3 Transmembrane domain -  ion pathway through the membrane
The actual pore of the pentameric ligand-gated receptors which is in contact with the 
passing ions is formed only by the M2 helices. The M2 helices are enclosed by the ring 
of M1 and M3 helices and are not in direct contact with the M4 helices on the periphery 
(Fig. 11).
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The M2s are oriented more or less perpendicularly  to the membrane plane and the 
pore  is  defined  by  the  amino  acid  side  chain  residues  pointing  inside  to  create 
constrictions  parallel  to  the  membrane  plane.  For  the  purpose  of  simplification  and 
better orientation the M2 helix residues of the first nAChR structure to be solved were 
assigned new numbers, starting with the lowest membrane residue carrying the number 
0’, up to the residue closest to the extracellular part of the membrane having the number 
20’ (Miyazawa et al., 2003). All structures solved later respect this numbering system 
and define the 0’ residue based on sequence alignment. If some residues, shown to be 
before the 0’ residue, are still within the membrane, they are numbered with negative 
numbers starting from -1’ and going from the 0’ residue lower along the M2 helix. 
The  structures  solved  to  date  indicate  the  existence  of  multiple  constrictions 
determining the ion pathway. Generally there are two main constriction sites on the M2 
helices, one in the middle and the second  closer to the intracellular side. The middle 
position is defined by the highly conserved leucine at the 9’ position (Alqazzaz et al.,  
2011).  This residue is a geometrical determinant of ion permeability in closed states 
(Fig.  12)  and together  with the V13'  and I16'  residues forms the hydrophobic gates 
(Miyazawa et al., 2003). The V13'S mutation lead to the gain-of-function phenotypes 
(Dang  et  al.,  2000).  The  L9'  mutations  to  Phe,  Tyr  or  Ala  cause  the  slower 
desensitisation in contrast to the Thr mutation  (Yakel et al., 1993). Its position differs 
among  the  different  conformational  states  of  receptors.  Even  though  the  relative 
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position  of  the  M2 helices  within  the  receptors  in  the  antagonist-bound/closed  and 
resting/closed conformation vary, the L9’ remains the main restriction determinant in all 
of these structures (5-HT3R, strychnine-GlyRα1 and apo-GluCl). The  ion pathway  at 
the P9’ position is blocked by the too small radius (~1.4 Å) in the closed GlyRα1 but is 
widely open (4-5  Å) in the open and desensitised state of the same receptor.  In the 
5-HT3RA serotonin-bound structure the M2 rotates by 13° in comparison to the apo 
structure,  causing  the  rotation  of  L9'  away  from  the  pore  (Basak  et  al.,  2018b). 
Additionally,  a  tilt  was  observed  at  the  S2'  position,  widening  the  vestibule  at  the 
intracellular end.
                              
In the apparently desensitised structures the L9’ is not a pore size limiting residue. 
All  the  structures of  desensitised receptors  known to date  present  the smallest  pore 
radius in the lower part of the M2. For the GlyRα1 in the closed state it is at the proline 
-2’ position (Du et al., 2015), for the nAChRα4β2 receptor, the channel is tightest at the 
E-2’ position (Morales-Perez et al., 2016), and for GABAA at the A-2’ position as well 
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(Miller  and  Aricescu,  2014) (Fig.  12).  As  mentioned  above,  these  residues  are 
responsible for the selectivity of the ion channels and thus the conserved residues at this 
position vary according to the channel  permeability  (Thompson and Lummis,  2003). 
Anion-selective  channels  usually  have uncharged  amino  acid  residues  here,  and 
cation-selective  channels  contain  mostly  negatively  charged  glutamic  acids  at  this 
position.
The X-ray structure of the 5-HT3RA was solved using stabilising nanobodies, which 
were shown to act as antagonists. The radius formed by the L9’ residues is about 4.6 Å, 
a width that might be too tight for hydrated Na+, which have a radius of about 4.7 Å. 
This  agrees  with  the  suggestion  that  the  structure  is  in  the  closed  conformation. 
Moreover, it is supported by the results of MD performed with the recently obtained 
structures  (Basak et al., 2018b) (and our structures presented in the 5.2.2 section). It 
shows that prediction of the pore de-wetting by MD is a better indicator of the pore 
permeability rather than the measurement of geometrical constriction. Interestingly, the 
comparison of the backbone within the structure with the open channels (GLIC and 
open GluCl) suggests a closer resemblance to these open structures rather than to the 
closed ELIC and GLIC structures,  which led to some speculation questioning if  the 
channel is really closed. The side chain of E-1’ was unfortunately not clearly defined in 
the electron density map and was modeled only as the most plausible rotamer, thus not 
allowing any further interpretation. The X-ray structure mostly agrees with the apo state 
receptor solved by cryo-EM, which supports the theory that the X-ray structure is of a 
closed state and as mentioned above, it is confirmed by the MD.
Different  parts  of  the  TMD were  proposed  to  be  a  predominant  location  where 
allosteric  modulators  bind  (Sauguet  et  al.,  2015).  Those  are  amphipathic  molecules 
including  anesthetics,  ivermectin,  ethanol,  as  well  as  lipids/detergents  (Hibbs  and 
Gouaux, 2011), (Basak et al., 2017), (Nury et al., 2011).
The presence of lipids is a very important factor influencing the functional properties 
of receptors, mediated by the transmembrane portion of the protein. First it was shown 
that nAChR solubilised by detergent maintains its ligand-binding capacity but does not 
allow ion flux (Sobel et al., 1977), requiring the presence of lipids to help regain its 
natural  functional  properties  (Epstein  and  Racker,  1978) (Fig.  13).  Based  on  the 
composition of the membrane naturally surrounding nAChR, tests probing the effects of 
the  addition of  cholesterol  and  of  phosphatidic  acid  (PA,  negatively  charged  head 
group) were done (Baenziger et al., 2000). Both of these lipids are able to maintain the 
coupling  between the  binding of  a  ligand and the  conformation  of  the pore.  In  the 
presence of phosphatidylcholine lipids only, the nAChR enters a so-called “uncoupled” 
state that differs from the desensitised state and has lost the capacity to transduce signal 
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from the binding site to the pore (daCosta et al., 2009). When the effect of lipids on the 
desensitisation process was further studied, the M4 helix, situated at the periphery of the 
membrane bundle and as such the perfect candidate for lipid interaction, was shown to 
play a role in this process, at least for nAChRs (daCosta et al., 2013).
Moreover, the GLIC receptor was shown to be sensitive to  docosahexaenoic acid 
(DHA) that induces the desensitised conformation of the receptor (Basak et al., 2017). 
DHA binds in between the M4 and M3 helices at the ECD-TMD level, inducing small 
changes in side chain residues of neighbouring amino acids (among them Phe260 from 
the M3 and Phe315 from the M4 helix). Another example of the TMD modulators are 
endogenous neurosteroids which interact with residues T305 (M3 of principal subunit) 
and Q241+W245 (M1 from consecutive subunit)  (Laverty et al., 2017).  (Baenziger et 
al., 2017) 
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1.5.2.4 The intracellular domain
Although  the  intracellular  domain has  been  shown to  play  an  important  role  in 
conductance  determination,  in  trafficking,  in  determining  life-time  kinetics  at  the 
synapse and also in protein-protein interactions, structurally it is the least well defined 
element of the Cys-loop receptors. The prokaryotic homologues lack the intracellular 
domain  completely  and  the  majority  of  the  structures  of  eukaryotic  receptors  were 
solved using mutants where the M3-M4 loop was replaced by short linkers. The M3-M4 
loop  comprises  of  the  MX  peripheral  helix,  in  cation-selective  pLGIC, on  the 
intracellular side of the membrane, followed by  an unstructured loop and by the MA 
helix, which becomes the M4 helix  at the membrane border (Fig.  5). The only partial 
structural  information  available  about  the  M3-M4  region comes  from  the  Torpedo 
nAChR structure  (Unwin, 2005) and from the 5-HT3RA structures  (Hassaine et  al.,  
2014) where a part of the unstructured domain, the post-M3 loop, and the MX and MA 
helices are resolved. For the nAChRα4β2 structure, the post-M3 loop and the MX helix 
were left in the expression construct (Morales-Perez et al., 2016). However, the loop 
between the MX helix and the M4 helix is absent in this structure, showing potential 
flexibility  of  the  unnatural  linker.  The  post-M3 loop  is  resolved in  the  very  recent 
GABAA  structures  but  the  existence  of  the  MX  in  anion-selective  pLGIC  remain 
unproven because of the poor densities at this level (Laverty et al., 2019; Masiulis et  
al., 2019). Interestingly, the importance of the length of the M3-M4 loop was studied in 
the 5-HT3R and it was shown that even a loop as short as 2 alanine residues is sufficient 
to obtain the functional receptor  (McKinnon et al.,  2012).  Varying the length of the 
alanine linker resulted in differentially active receptors, suggesting that it is not only the 
loop  length  that  matters  but  also  the  secondary  structure  of  the  linker,  which  may 
influence proper receptor functioning and expression of the protein (McKinnon et al.,  
2012). 
Functional studies of the 5-HT3R have revealed the importance of the intracellular 
domain  region,  particularly  that  of  the  residues  of  the  MA helices  influencing  the 
single-channel  conductance  of  the  receptor  (Kelley  et  al.,  2003).  The  residues 
responsible for the difference in conductivity between the homo- (A subunit only) and 
heteropentamers (AB receptor) were determined to be R416, R420 and R424 (Fig. 14) 
as described in detail in the section 1.4.1.
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The  pathway  for  ions  through  the  ICD  region  is  still  to  be  elucidated  and  is 
speculated not to continue along the pore axis. Cations passing through the 5-HT3R are 
putatively  thought to exit through the lateral portals at the level of the M3-MX loop 
below which the rings of positively charged arginines are located, whose function might 
be the repulsion of the positively charged ions or rather the formation of the salt bridges 
(Kozuska et al., 2014). Further down the membrane the MA helices expose hydrophobic 
residues on the inside of the bundle and this region represents the tightest part of the 
whole pore vestibule with a minimal width of about 4.2 Å.
Regarding  interacting  partners  of  the  5-HT3R,  the  only  known  protein binding 
directly to the ICD is the resistance to inhibitors of cholinesterase type 3 protein (RIC3) 
(Nishtala  et  al.,  2016),  known to  be  a  protein  chaperone.  Its  presence  enables  the 
maturation of multiple Cys-loop receptors  (Halevi et al., 2002, 2003; Lansdell, 2005;  
Walstab et al., 2010).
1.6 X-ray crystallography and cryo-electron microscopy of the 
membrane proteins
During  the  recent  years  we  have  seen  a  complete  revolution  in  macromolecular 
structure  determination.  X-ray  crystallography  was,  for  a  long  time,  the  main  tool 
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supplemented  by  NMR.  However,  methodologic  development  and  technical 
advancement have made it possible to determine the first high-resolution structures of 
membrane proteins by single-particle  cryo-electron  microscopy in 2013  (Cao et  al.,  
2013; Liao et al., 2013). Since then the ratio of membrane protein structures solved by 
X-ray crystallography compared to cryo-EM has decreased  (Fig.  15),  with cryo-EM 
structures representing almost 37% of all membrane protein structures solved during the 
first four months of 2018 (Cheng, 2018).
Without  considering  the  common  difficulties  during  the  overexpression  and 
purification of membrane proteins, both methods have their one specific bottleneck to 
surpass  on  the  way  to  atomic  resolution  structures.  X-ray  crystallography  requires 
crystal  growth,  which  is  generally  a  very  challenging  and  complex  procedure. 
Moreover,  crystal  growth  of  membrane  proteins  is  complicated  by  the  presence  of 
detergent micelles. Solubilised membrane proteins might not be stable enough to form 
crystals, plus the presence of the micelle may limit  the possibility of crystal contact 
formations.  Multiple  techniques  aiming to solve this  problem have been introduced. 
Among them are the use of antibodies/nanobodies to increase the potential  effective 
surface  for  crystal  contact  formation  and  the  insertion  of  proteins  into  the  lipidic 
mesophases that may mimic more native-membrane-like conditions.
The cryo-EM method demands the same high-quality protein sample regarding its 
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purity,  monodispersity  and stability  as X-ray crystallography.  Crystals  are no longer 
required but free micelles might pose a problem. They increase the noise and make data 
analysis more complicated (especially for small proteins analysed in combination with 
large micelle-forming detergents). To eliminate this problem, detergent was replaced by 
amphipol at least in the early cryo-EM studies of membrane proteins. Nowadays, the 
structures  of  membrane  proteins  are  solved  using  not  only  amphipols (Cao  et  al.,  
2013) but also detergents (Du et al., 2015) and nanodiscs (Efremov et al., 2014; Gao et  
al., 2016). Another obstacle is the need to have multiple orientations of protein particles 
in  the  holes  of  the  frozen  grid.  Fluorinated  detergents  can  be  a  helpful  tool  for 
membrane proteins  (Basak et al., 2017; Efremov et al., 2014), but one should keep in 
mind the fact that those detergents can potentially influence the membrane proteins as 
has been recently shown for the ryanodine receptor (Willegems and Efremov, 2018).
At  the  beginning  of  my  PhD  the  only  5-HT3R  structure  available  was  the 
crystallographic  structure  of  the  m5-HT3RA  receptor  obtained  using  stabilising 
nanobodies. We wanted to solve other conformational states of the receptor using X-ray 
crystallography  but  the  fast  development  of  cryo-EM  and  the  first  high-resolution 
structures of membrane proteins solved via the cryo-EM method encouraged us to start 
using this method as well. Moreover, the m5-HT3R is an ideal candidate for cryo-EM 
due to its reasonable size (~250 kDa) and symmetry. The methodology of the X-ray 
crystallographic  and  cryo-EM  structural  studies  together  with  the  results  and  their 
discussion follows after the Objective of the thesis section.
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Objective of the thesis
2 Objective of the thesis
Due  to their  important  role  in  neuronal signaling  and  their  potential  for 
pharmacological intervention, many receptors from the pLGIC superfamily are studied 
extensively, both functionally and structurally. Even though intensive efforts are being 
made, our knowledge of the signal transduction within the receptor remains limited. The 
best way to understand the mechanism of the receptor function is the co-interpretation 
of functional and structural data. Although this thesis focuses on structural studies, all 
the steps  were planned taking into account  the functional  properties  of the receptor 
known  from  the  literature  and  complementary  functional  experiments  were  carried 
when needed. 
As a follow up of the  already described crystallographic structure of the 5-HT3RA 
receptor solved up to a resolution of 3.5 Å, the aim of my thesis was to try to obtain the 
structure(s)  of  an other state(s)  and/or  potentially  obtain  a structure  with  a better 
resolution,  which  would  allow  better  structure-function  interpretation.  In  the  initial 
stages,  the crystallographic approach was prefered; we quickly realized that the rapidly 
developing cryo-electron  microscopy technique  was to  become the best tool  for the 
structural studies of our target. Thus, the main goals of my thesis were:
I) Crystallography: 
Use of nanobodies, which were shown to stabilise the receptor and help to create the 
crystal  contacts,  for  co-crystallisation  with  the  receptor  using  a   classical  vapour 
diffusion method to obtain the receptor locked in (an) other conformation(s). 
Use of the lipidic cubic phase to obtain a better resolution structure of the 5-HT3RA.
Co-crystallisation of the receptor with drugs known to improve its stability to obtain 
better resolution or block the receptor in the open state.
II) Cryo-EM:
To obtain the closed conformation of the receptor as a confirmation of / comparison 
to  the  existing  crystallographic  structure  and  potentially  obtain  a  structure of  the 
desensitised and/or open state of the receptor. 
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3 The m5-HT3R isolation, purification and treatment
3.1 The m-5HT3R preparation - materials and methods
3.1.1 DNA construct(s)
Even if I have generated a variety of constructs during my PhD (including 5-HT3 
receptor constructs for expression in Leishmania tarentolae cells, ɑ4β2 constructs fused 
with GFP ), most of the work described here was performed with a single construct 
encoding for the full-length homomeric receptor. It  originates from previous work on 
the homomeric 5-HT3RA (Hassaine et al., 2013) . 
The DNA construct for the mouse 5-HT3RA  is in a pcDNA5/TO vector, enabling 
transient transfection of mammalian cells  (typically 293F cells),  generation of stable 
inducible cell lines in HEK-Trex cells, and injection into  Xenopus laevis oocytes for 
TEVC functional assays. The insert is composed of a signal sequence, four consecutive 
Strep tags for purification,  a TEV cleavage site  and the mature 5-HT3RA sequence 
(depicted in the Extended Data Figure 1 of our paper (Polovinkin et al., 2018)).
3.1.2 Cell culture 
The  adherent,  stable,  inducible,  cell-line  HEK 293  5-HT3RA receptor  originates 
from previous work on the homomeric 5-HT3RA receptor (Hassaine et al., 2013). This 
cell line expresses constitutively the tetracycline repressor, preventing the expression of 
the target protein in the absence of tetracycline, and it also bears copies of the gene of 
interest.  This cell  line was adapted to be used not only for roller  bottle  expression, 
which  is  a  tedious  and  manpower-heavy  technique,  but  also  for  expression  in 
suspension cultures. 
For  this  purpose  we used the  adherent  stable  cell  line  HEK 293 5-HT3RA.  We 
detached  the  cells  from an  85% confluent  25 mL flask  (Dutscher)  with 5 mL PBS 
(Gibco) by gently pipetting up and down and we transferred 1 mL of the cell suspension 
into  a  100 mL  Erlenmeyer  tube  containing  10 mL  of  FreeStyle  media  (Gibco) 
supplemented with 10% of newborn calf serum (Corning). The serum concentration was 
halved every 3rd day during the passaging of the cells. Cells were plated to the density 
of 0.8 million cells/mL. At every passage, the amount of antibiotics was increased in a 
stepwise manner up to the final concentration of 5 μg/mL of Blasticidin and 100 μg/mL 
of Hygromycin B.  Cells were grown while shaking  in  an orbital shaker at 37 °C, 5% 
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CO2 and 90 rpm.
Typically, expression was induced by adding 4 mg/L of tetracycline to batches of 2 L 
of cultures at 2.106  cells/mL. The day after induction 4 mM valproic acid was added. 
Cells were harvested 48-72 h after induction.
3.1.3 Isolation of the 5-HT3RA
I have optimised the purification protocol of the receptor described in (Hassaine et  
al., 2014) and only the final version is described in the following sections. 
3.1.3.1 Membrane preparation
To avoid contamination by the cytosol debris, I performed a membrane preparation 
step prior to the solubilisation step. 
The collected cells were resuspended in resuspension buffer (10 mM HEPES pH 7.4, 
1 mM EDTA and the inhibitor mix CLAPA (1µg/ml  Chymostatin,1µg/ml Pepstatin, 
1 µg/ml Leupeptin, 1 µg/ml Antipain and 4µg/ml of Aprotinin)) using 10 mL of buffer 
per  1 g  of  cells.  Cells  were  kept  on  ice  and  lysed  using  the  T25  Ultra  Turrax 
homogeniser by five consecutive 30 s steps with increasing rotation of the homogeniser 
followed by a 1 min homogenisation at maximal speed. A low speed centrifugation was 
performed  to  remove  unbroken  cells  (4000  x  g,  20 min,  4 °C).  The  low-speed 
supernatant was further spun down using ultracentrifugation (120 000 x g, 1 h, 4 °C). 
The supernatant was decanted and the pellets containing the membranes were stored at 
-80 °C.
3.1.3.2 Solubilisation
Membrane  proteins  contain  hydrophobic  parts  that  are  immersed  in  cellular 
membranes. To extract this hydrophobic moiety from the membrane and keep it intact 
and soluble  in an aqueous solution, we use amphipathic molecules. These molecules 
consist  of  hydrophobic  regions  which  are in  contact  with  the  transmembrane 
hydrophobic part of the protein and of hydrophilic polar group/s which is/are oriented 
into the solution. The most commonly used surfactants are detergents, which are able to 
extract  the  protein  from the  membrane  and maintain  it  in  solution,  and  amphipols, 
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which  are  not  suitable  for  the  extraction  but  work  well  for protein  stabilisation  in 
solution  (Seddon et al., 2004). Detergents are composed of a hydrophobic carbon tail 
and a  polar  head.  Each detergent  has  specific properties  regarding its  harshness,  its 
capability to extract the protein out of the membrane, the level of the native membrane 
lipids that it is able to remove from around the extracted protein, and its ability to form 
micelles (the  self  assembly  of  single  detergent  molecules  into  a  supramolecular 
structure). An  important  property  of  a  given  detergent  is  its  critical  micellar 
concentration  (CMC: the  concentration  border,  which  once  exceeded  initiates  and 
favours the formation of the micellar formation over free detergent). For solubilisation 
of  membrane  proteins,  high  detergent  concentrations  can  be  necessary  (typically 
10-100xCMC); but to keep the protein soluble it is generally sufficient to keep detergent 
levels at at least 1xCMC.
Our membranes  were resuspended in the solubilisation buffer (50 mM Tris pH 8, 
500 mM  NaCl  and  the  inhibitor  mix  CLAPA)  using  a  1:25  mass  ratio  of 
membranes:buffer.  After  homogenisation  on  the  magnetic  stirrer,  0.15%  C12E9 
(50xCMC) was used to solubilise  the receptor.  Solubilisation was performed on the 
magnetic  stirrer  for  1.5 h at  4 °C followed  by ultracentrifugation (120 000 x g,  1 h, 
4 °C ). The supernatant contained the solubilised protein. 
3.1.4 Purification of the 5-HT3RA
3.1.4.1 Affinity chromatography
The  Strep  tag  on  the  N-terminus  of  the  receptor  was  used  for  affinity 
chromatography on the Strep-Tactin resin (IBA). For  a  typical  purification  we used 
1.5 mL of the resin/1 g of membranes. We used the gravity-flow set up in columns. The 
resin was equilibrated with 5x column volumes (CVs) of equilibration buffer (50 mM 
Tris pH 8, 500 mM NaCl and 0.01% C12E9 ),  the solution containing the solubilised 
protein  was loaded once on the  column and washed  with 5 CVs of  washing buffer 
(50 mM Tris pH 7.4, 125 mM NaCl and 0.01% C12E9).  The  protein was eluted with 
3 CVs  of  the  elution  buffer  (50 mM  Tris  pH 7.4,  125 mM  NaCl  and  0.01% C12E9 
supplemented with 5 mM d-desthiobiotin). The protein was concentrated using Amicon 
concentrators (Merck Millipore) with a 100 kDa molecular weight cut-off.
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3.1.4.2 Size exclusion chromatography
Size  exclusion  chromatography  (SEC)  on  a Superose  6  10/300 GL column  (GE 
Healthcare)  was  performed  after  enzymatic  treatments  (see  the  following  section 
3.1.5.1)  to  separate  the  cleavage  products  or  after  the  amphipol  exchange  (section 
3.1.5.2)  to  remove  the  remaining detergent.  The  column  was  equilibrated  in size 
exclusion  buffer  (50 mM  Tris  pH 7.4).  For  crystallographic  purposes  the  buffer 
contained 0.01% C12E9 and 125 mM NaCl. For the cryo-EM experiments,  the buffer 
contained  0.01% C12E9 and  only  65 mM NaCl.  The  SEC performed  after  amphipol 
exchange was done using the size exclusion buffer (50 mM Tris pH 7.4, 125 mM NaCl) 
in the absence of detergent. The 5-HT3RA eluted from the column at around 13.7-14mL 
and no significant  shift  was  observed  for  the  protein  in  amphipol  compared  to  the 
protein in detergent.
3.1.5 Treatement of the 5-HT3RA
3.1.5.1 Enzymatic treatment
The 5-HT3A contains a partially unstructured intracellular domain, which causes the 
formation of badly diffracting crystals and we were thus using limited proteolysis by 
trypsin (0.0125:1 mass  ratio of trypsin:protein,  2 h at 30 °C) to cleave this region out. 
SEC was performed immediately at the end of incubation with trypsin, in order to avoid 
excessive cleavage which could lead to protein degradation. 
 On the other hand, this unstructured part seemed to prevent aggregation when the 
protein  was used for cryo-EM and thus only the N-terminal Strep tags  were removed 
when  we  prepared  samples  for  cryo-EM.  They  were cleaved  by  the  TEV  protease 
(0.04:1 mass ratio of TEV protease:protein, overnight (ON) at 4 °C). 
The 5-HT3RA has 3 N-glycosylation sites. Glycosylations added heterogeneity and 
were perturbing crystallogenesis. We used PNGase F, which is an amidase that cleaves 
between the innermost GlcNAc and the asparagine residues of high mannose, hybrid, 
and complex oligosaccharides from N-linked glycoproteins. Cleavage  was carried out 
using the 0.1:1 mass ratio of PNGase F:protein (2 h at 4 °C).
3.1.5.2 Amphipol exchange
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The cryoEM structure of TRPV1 (Cao et al., 2013) was a landmark, in the field of 
membrane protein structures solved by this method. That structure was obtained with a 
sample  solubilized  in  amphipol,  and was  the  reason why we and others  performed 
experiments in amphipol.  It has different properties compared to the detergent. It does 
not form micelles but wraps the protein around its hydrophobic part, thus once all the 
proteins are protected by the amphipol molecules, no further free amphipol is needed in 
the solution. Amphipol is a long polymer composed of a different ratio of the monomers 
containing polar and nonpolar side chains  (Tribet  et  al.,  1996; Zoonens and Popot,  
2014). We used commercially available amphipol A8-35 (Anatrace) where the number 
35 indicates the percentage of the overall  amount of polar monomers present in the 
polymer. In principle, once amphipol is added to the protein-detergent solution, it starts 
to compete with the detergent for the hydrophobic parts of the protein. The exchange 
can only be completed by removal of the detergent from the solution either by dialysis 
or by the use of polymeric beads. We decided to use the bio-bead method rather than 
dialysis  and  we  optimised  the  detergent-amphipol  exchange  protocol  based  on  the 
publication  explaining  the  use  of  the  bio-beads  (Rigaud  et  al.,  1997) for  optimal 
detergent removal and the publication describing the exchange of the TRPV1 receptor 
from detergent into amphipol (Liao et al., 2013). Here I present only the final protocol.
First the protein was concentrated to the final concentration of 0.5 mg/mL. Then 
amphipol A8-35 was added in a 4:1 mass ratio of amphipol:protein and the solution was 
incubated  (3 h,  4 °C,  mixing).  After  the incubation  the Bio-Beads (BIO-RAD) were 
added in a 106:1 mass ratio of Bio-Beads:protein and incubated overnight at 4 °C while 
mixing,  to  remove  the  detergent  from  the  protein-detergent-amphipol  solution. 
Bio-beads  with  the  bound  detergent  were  then  removed  from the  protein-amphipol 
solution and SEC was performed as described in the section 3.1.4.2.
3.2 The m5-HT3R preparation - results
My project  started  as  a  follow up of  the  structure  of  the  m5-HT3RA solved by 
crystallography. At the beginning I took over the protocols for the protein purification 
and crystallisation of the receptor  (Hassaine et al., 2014) and I tried to optimise them 
with multiple aspects in mind, specifically aiming to increase the yields, shorten the 
purification  time  and  lower  the  costs.  The  initial  protocol  comprised  of  cell 
homogenisation,  membrane  separation  by  ultracentrifugation,  protein  solubilisation 
followed by ultracentrifugation, which led to solubilised protein solution. The next step 
was a filtration which allowed us to proceed with Strep-Tactin affinity chromatography. 
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Pre-packed  Strep-Tactin  columns  were  used  and  purification  was  done  using  the 
peristaltic pump loading the sample overnight. To improve homogeneity of the sample 
and to remove potential flexible parts of the protein, deglycosylation was carried out by 
PNGase F in a ratio of  1 mg : 0.1 mg receptor to deglycosylase (2 h shaking at 37 °C) 
and limited proteolysis was done by trypsin in a ratio of 1 mg : 0.013 mg receptor to 
protease (incubated 2 h at 30 °C).
I optimised the solubilisation step, trying to lower the concentration of detergent used 
and to shorten the incubation time. In contrast to the initially quite high concentration of 
C12E9 (1%) used for 3 h at 4 °C,  I demonstrated that using a concentration of 0.15% for 
1.5 h at 4 °C solubilised the protein to the same extent (Fig. 16).
A very time-demanding step was the filtration of solubilised protein solution through 
0.22 μm filters.  This step was mandatory because of the clogging of the pre-packed 
Strep-Tactin column filter. We tested the gravity flow set-up and as neither the yield nor 
the purity of the protein was affected  (Fig.  17) we switched to this approach which 
saved us ~ 2 h of filtration.
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A relatively expensive part of sample preparation was the usage of PNGase F. We 
decided to  adapt  the protocol  from  (Loo et  al.,  2002) to  purify PNGase F in-house 
instead of using the commercially available enzyme. I adapted it and we now express 
periplasmic PNGase F and purify it using NiNTA and size exclusion chromatography. 
We verified the activity of in-house purified PNGase F and tested the conditions for its 
activity. Compared to the initial 2 h incubation at 37 °C we have shown that the same 
level of deglycosylation can be achieved even when the reaction is incubated at 4 °C. 
This might prevent protein denaturation caused by increased temperature (Fig, 18).  
55
 
 
 
 
 
 
The m5-HT3R isolation, purification and treatment
The isolation, purification and enzymatic treatment of 5-HTRA are carried out over 2 
days. Generally, the yields vary from 0.2 - 0.3 mg of pure and treated protein per 1 g of 
membrane  fraction  after  the  final  size  exclusion  chromatography,  where  a  nice 
homogeneous peak corresponding to the pentameric receptor is observed (Fig, 19). 
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4 Crystallography
4.1 Crystallography - materials and methods 
4.1.1 Vapour diffusion trials
All the screening was carried out on the High-Throughput crystallography platform 
(HTX-lab) at the EMBL in Grenoble.
Manual plates were mostly set up using a protein concentration of ~8 mg/mL. During 
the optimisation process different ratios of the protein:reservoir  drops were used. To 
slow down the growth kinetics Ali-oil was used to cover the reservoir in the hanging 
drop  set  up.  Microbatch under-oil  crystallography  was  performed.  Different  initial 
concentrations of the protein were used (from 1 mg/mL up to 10 mg/mL). The seeding 
method  used  was  seeding  into  the  clear  drops.  Stepwise  dehydration  and  direct 
dehydration were tested to improve the crystal X-ray diffraction. 
4.1.2 The lipidic cubic phase (LCP) trials
The protein was concentrated typically to 40 mg/mL. In one of the trials the VHH15 
was  used to  further  stabilise  the  receptor  but  its  use  increased  the  hydrophilic  part 
pointing out of the lipid bilayer, which is not favourable for the LCP method and thus 
we  used  mostly  the  receptor  alone.  In  collaboration  with  the  platform  for 
high-throughput  LCP crystallisation  (Valentin  Gordeliy’s  group,  currently  at  EMBL 
Grenoble),  we  set  up  multiple  plates.  Commercial  screens  (Cubic  phase  I and II 
(QIAGEN) and MemMeso  (Molecular  Dimensions))  as  well  as  plates  based  on the 
optimisation conditions arising from the positive vapour diffusion trials.
4.1.3 The detergent screen with a focus on further use in X-ray 
crystallography
We re-screened  a  dozen  detergents  (C12E9  ,  C12E10  ,  DDM, MNG3,  OGNG, OG, 
cymal5, cymal6,  cymal7, LDAO, LAPAO, FosC12), measuring the receptor stability 
upon heating,  with the aim of selecting one with a shorter hydrophobic tail  forming 
smaller micelles to allow for the formation of better protein-protein crystal contacts. We 
followed the intrinsic  fluorescence of  the protein's  tyrosines and tryptophans during 
thermal denaturation of the receptor. Addition of 9% detergents was followed by 15 min 
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incubation on ice and then the measurement was performed. Typically the measurement 
was performed in the range of 20-100 °C using 2 °C/min steps. The fluorescence at two 
wavelengths,  330  and  350  nm  was  recorded.  The  350/330  nm  ratio  of  the  two 
wavelengths was plotted against temperature and represents the unfolding transitions. 
The data were measured on the Prometheus (NanoTemper).
As a complementary method we used SEC performed after the heat shock. Protein 
was purified using C12E9  during solubilisation and for stability  in solution.  Different 
detergents were added at the 1% concentration and the mixture was incubated 15 min at  
55 °C. After ultracentrifugation to remove potential aggregates, the sample was injected 
onto a Superose 6 column equilibrated with buffer containing 0.01% C12E9. The same 
concentration of this detergent was used in the running buffer (running buffer as for 
protein purification, see 3.1.4.2).
4.1.4 Blue native electrophoresis
Native gels can qualitatively characterise the size of protein complexes. Regarding 
protein-protein  interactions  this  method  can  even  answer  binding  stoichiometry 
questions.  We used native  electrophoresis  for  the  estimation  of  the  binding ratio  in 
between nanobodies and the 5-HT3A. 
All  the  buffers  and  procedures  were  prepared  and  performed  according  to  the 
NativePAGE Novex® Bis-Tris Gel System manual (Novex, LifeTec MAN0000557). 
Briefly, 6% polyacrylamide gels were cast. 10 µg of the purified 5-HT3 were mixed 
with the 1:2 molar  ratio  of  one receptor  subunit:VHH and incubated  on ice for  10 
minutes. The sample was mixed with the sample buffer (for reference see the manual 
mentioned above) and 1 µL of 0.4% Coomassie G-250 per 10 µL of mix. Anode and 
cathode  buffers  were  prepared  according  to  the  manual  and  filled  into  the 
electrophoresis system. We loaded the samples onto the gel prior to complete filling of 
the apparatus with the cathode blue buffer for better visualisation. The electrophoresis 
was performed either in the cold room or on ice at 150 V for ~2 h. When the run is 
complete, the blue cathode buffer, migrated through the gel, should start appearing in 
the normally transparent anode buffer. Extensive destaining of the gel is needed. The 
gel was first fixed by immersion in 100 mL fixing solution (containing 40% methanol 
and  10%  acetic  acid),  then  microwaved  for  45 s  and  incubated  on  the  shaker  for 
20 mins. The fixing solution was decanted. The gel was then destained in 8% acetic 
acid, microwaved for 45 s and incubated until the gel background became transparent.
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4.2 Crystallography - results
4.2.1 Crystallisation of the m5-HT3RA using nanobodies
4.2.1.1 VHHs
Camelids  possess  antibodies  made  of  heavy  chains  only.  Engineered  terminal 
domains of these antibodies are called nanobodies or VHHs. These domains retain their 
antigen-binding  ability,  their  typical  size  is  ~15  kDa,  and  they  can  generally  be 
overexpressed in E. coli. The antigen-binding paratope is made up of 3 complementary 
binding regions (CDR1-3).
The use of nanobodies has multiple  benefits  in structural  biology (Pardon et  al.,  
2014). They might help to solubilise the protein by increasing its polar surface and they 
can  stabilise  the  protein,  which  reduces  heterogeneity  of  the  sample.  Their  use  in 
crystallography can be instrumental in solving the structures of unknown proteins by 
enabling molecular replacement. Additionally their presence might also help to promote 
crystal growth by supporting the formation of crystal  contacts, as was the case with 
crystallisation of the m5-HT3RA/VHH15 complex  (Hassaine et al., 2014). After this 
initial success, our strategy was to try to find another nanobody, which would stabilise 
the receptor in another conformation. 
Nanobodies are obtained following immunisation of the animal (see  Pardon et al.  
(2014) for methods). The protein of interest is injected into an animal and its immune 
response yields new antibodies. A library of all VHHs is created and those interacting 
with the protein of interest are selected by phage display and then assayed using ELISA 
tests  with  the  purified  protein.  The  nanobodies  used  in  our  studies  were  from 
collaborators in Marseille. The information available to us are the VHH sequences and 
their  ELISA  score.  For  better  orientation  in  our  library  composed  of  about  15 
nanobodies we sorted them into six groups according to their sequence similarity (Fig. 
20). 
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4.2.1.2 Co-crystallisation 
Following the current trend in crystallography, after the selection of nanobodies from 
sequentially  different  groups (one for each group)  we used the service of  the HTX 
laboratory on campus to set up commercial screens (generally starting with 6 screens: 
PACT, PEGs, JCSG and Wizzard I+II). 
Protein  was  purified  as  described  in  section  3.1.3-4.  After  size  exclusion 
chromatography, peak fractions were pooled together and concentrated to ~8 mg/mL. 
Before  crystallisation,  the  protein  was  mixed  with  VHH  in  a  1:2  molar  ratio, 
(1 monomer  of  the  m5-HT3RA  with  an  excess  of  2 VHHs).  This  mixture  was 
supplemented  with  1  mM of  Cymal-6.  Here  the  role  of  Cymal-6  is  not  to  further 
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stabilise  the  complex,  as  demonstrated  by  our  thermostability  data  (Fig,  22).  We 
hypothesise that the positive effect of Cymal-6 during crystallisation is caused by a 
decrease of the micelle size that promotes protein/protein contacts and results in better 
crystal packing.
Working towards our goal, we focused on the nanobodies sufficiently distinct from 
VHH15,  hoping  that  they  will  stabilise  the  receptor  in  another  conformation. 
Unfortunately,  even  though  we  have  access  to  biophysical  methods  to  characterise 
receptor-VHH interactions, we lacked a way to characterise them functionally, which 
would  probably  provide  the  optimal  criteria  for  selection  of  the  crystallisation 
candidates.
Using 7  different  nanobodies  we obtained  157 hits,  which  largely  exceeded  our 
expectations. We focused mainly on the conditions which were as different as possible 
from the conditions under which the structure of receptor in complex with VHH15 was 
obtained.  Manually,  we  reproduced  more  than  70  conditions  selected  to  maximise 
diversity. The majority of them gave crystals. The synchrotron measurements confirmed 
that these were, apart from very few exceptions, protein crystals with a poor diffraction, 
ranging from ~30 to ~9 Å at most. We optimised all conditions that yielded crystals but 
this did not improve their diffraction. Altogether we shot around 550 crystals.
The chemical compositions of the hits obtained were very divergent and we could 
not observe any clear  pattern.  Crystals  grew at  different  pHs (5-10),  using different 
organic and inorganic salts and PEGs (from 3350 - 10000) (see examples in (Fig. 21)). 
Changes in chemical composition of the mother liquor (type and amount of ingredients) 
did not  improve the  diffraction  by our  crystals  and we focused mainly  on physical 
parameters.  From the  classical  methods  used  for  diffraction  improvement  we  tried: 
different  growth  temperatures,  seeding,  dehydration  and  growing  under  oil  using 
microbatch  crystallisation.  Using  recently  developed  methods  we  also  tried  to  use 
CrystalDirect plates, which make it possible to shoot crystals without fishing, directly in 
the plate. This approach reduces possible manipulation damage but it is compatible only 
with room-temperature measurements.  Except for the micro-batch method, all  others 
listed  led  to  crystals  but  did  not  affect  diffraction.  We  collected  data  of  crystals 
diffracting to 9 Å in the hope of further processing. We were able to determine the 
space group of crystals grown with two different VHHs but for none of them we were 
able to get a molecular replacement solution. 
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Neither  the  use  of  the  nanobodies  at  our  disposal  nor  the  optimisation  of 
crystallisation conditions led to X-ray diffraction of sufficient quality from any of the 
many  crystals  obtained.  We  thus  concluded  that  larger  changes  were  required  and 
started  to  re-evaluate  the  sample  preparation  protocol.  The  choice  of  detergent 
influences  solubility,  stability  and  of  course  plays  an  important  role  during 
crystallisation. For instance, the crystal quality of the m5-HT3RA/VHH15 complex had 
been improved when Cymal-6 was used as a supplement  to C12E9,  possibly because 
Cymal-6 reduced  the  micelle  size  and thus  favoured  protein-protein  contacts  in  the 
crystals. Consequently,  we performed a new thermal  stability  detergent  screen using 
NanoTemper’s Prometheus and SEC (see 4.1.3). We observed a correlation between the 
length of the carbon tail and the protein stability (see below). Although detergents with 
longer carbon chains were better  at  stabilising the receptor,  some of the shorter tail 
detergents  stood  out  from  the  screen.  Namely  the  Cymals  and  undecyl-maltoside 
(UDM), the latter  being the detergent used for crystallography of the nicotinic α4β2 
receptor (Morales-Perez et al., 2016).
Figure  22 depicts  thermal  denaturation curves for the Cymal series of detergents, 
where an effect of the carbon tail  length was observed, with Tm(Cymal-5)  = 52  <℃  
Tm(Cymal-6)  =57  < Tm℃ (Cymal-7)  = 60  < Tm℃ (C12E9)  = 64 . The comparison of℃  
C12E9 and UDM revealed that UDM might also be a good candidate for crystallographic 
studies  of  5-HT3RA.  These  detergents  stabilise  the  receptor  enough to be  used  for 
crystallography, while potentially enabling easier formation of protein-protein contacts.
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Because of its similarity to DDM in which the receptor remains active and in view of 
the recently solved structure of the other Cys-loop receptor in this detergent, we decided 
to  proceed with  UDM. Moreover,  the  size  exclusion  chromatography  profile  of  the 
m5-HT3R in presence of UDM as compared to C12E9 looked very encouraging (Fig. 23)
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Based on our previous experience with the m5-HT3A receptor we set up he PEGs 
screen and surprisingly observed 5x more promising hits (objects rather than crystals) in 
the conditions where UDM was used compared to where C12E9 was used, even without 
the  use  of  nanobodies.  At  this  point,  the  cryo-EM started  to  provide  early  positive 
results and we decided to focus mainly on it and not to continue with crystallography. 
4.2.1.4 Biochemical characterisation of the nanobodies
From all of the above-mentioned, it is clear that it is not possible to try extensively 
the combination of all approaches with all different nanobodies and all crystallisation 
conditions.  The  difficulties  encountered  emphasised  the  need  for  better  biophysical 
characterisation of our nanobodies. 
Looking at other examples of Cys-loop receptors crystallised with chaperones (either 
Fabs  (Hibbs and Gouaux, 2011) or VHHs) we noted that in all successful cases there 
were 5 chaperones bound per receptor (one per subunit). Thus we sought for a method 
to determine the binding ratio between the receptor and nanobodies. We tested native 
electrophoresis for this purpose. The receptor alone and the receptor pre-incubated with 
VHH15, which binds in a 5 to 1 ratio in the crystal structure, were used as references. 
Early  results  indicated  clearly  the  difference  between  these  two  samples  but  the 
resolution was not good enough. Thus, we turned to BlueNative electrophoresis  and 
replaced the detergent with amphipol. This approach gave us an estimate of the binding 
ratio (Fig. 24). 
For example, VHH4 is very closely related in sequence to VHH15 (97% sequence 
similarity / 6 point mutations), indicating that it should bind in the same ratio; indeed 
those  two  complexes  migrate  to  the  same  position  on  the  gel.  Interestingly, 
preincubation with nanobody VHH10 does not seem to affect the receptor migration on 
the  BlueNative  electrophoresis  gel  and  we  were  able  to  confirm  the  lack  of  this 
nanobody in the corresponding crystals by SDS PAGE (data not shown). 
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Another important parameter influencing the stability of the complex is the binding 
affinity  of  the  antibody  to  the  receptor.  We  performed  labeled  microscale 
thermophoresis and we were able to demonstrate that this method is not appropriate in 
our case (extensive trials, results not shown). The conditions of the protein labeling led 
to  m5-HT3R  denaturation.  The  measurement  obtained  using  the  non-precipitated 
fraction of labeled protein gave an uninterpretable binding isotherm. Surface plasmon 
resonance seems to be a good alternative for assessing protein-protein interactions but, 
as we know from the trial  with VHH15, the single cycle  kinetics  is  the only mode 
possible, somehow complicating data interpretation. 
Finally,  we  lacked  easily  accessible  functional  tests  for  the  elucidation  of  the 
nanobody effect on the protein stability. Functional tests would be probably the best 
indication of stability when looking for the nanobody stabilising the receptor in another 
conformation than VHH15, which acts  as an antagonist.  Some of the experiments  I 
performed on the expression optimisation were reported in a case study in Membrane 
Protein Structure and Function Characterization book (Hassaine et al., 2017).
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5 Electron microscopy
Currently,  electron  microscopy is  finding its  place  next  to  the  other  near-atomic 
resolution structural determination methods, such as X-ray crystallography. It is about 
70 years ago when the first biological sample was imaged using EM and since then a 
huge amount of progress was achieved. The electrons being scattered by the air required 
the  evacuation  of  the  microscope  column  and  thus  the  sample  also  needed  to  be 
dehydrated, which caused the limited contrast of the images  obtained  - micrographs. 
This introduced the need for a contrast increase and  that's how negative staining EM 
appeared  (Huxley and Zubay, 1961). In negative staining, the electron-dense solution, 
mostly  uranyl  acetate,  surrounds  the  specimen  being  observed  and  increases  the 
contrast. Passing through the imaging of the 2D crystals kept dehydrated in the glucose 
solution, this led to a resolution of about 7 Å (Henderson and Unwin, 1975), but the real 
breakthrough came with the routine use of sample freezing and the introduction of the 
cryo-stage into the microscope. That was the beginning of the cryo-EM method as we 
know it today. Nowadays, the sample in aqueous solution is rapidly frozen by the liquid 
ethane,  allowing  formation  of  the  amorphous  solid  phase  instead  of  crystalline ice, 
which had resulted in biological sample degradation in the past. 
5.1 Electron microscopy - material and methods
5.1.1 Negative stain EM of m5-HT3RA
As an initial  quality control we performed  negative-staining transmission electron 
microscopy using the electron microscopy platform of IBS. Purified sample (around 1 
mg/mL)  was  deposited  on  a  glow-discharged  carbon  grid  and  stained  with  uranyl 
acetate pH 7. Images were taken with a Tecnai12 Microscope (FEI) operating at 120 
kV, a LaB6 electron source and an Orius 1000 GATAN camera.
5.1.2 Cryo-EM of the m5-HT3RA
During the cryo-EM sample optimisation we performed multiple tests. Samples of 
different concentrations were used, starting from 0.5 up to 24 mg/mL. We used different 
commercially  available  grids.  Samples  were  frozen using  a  variety  of  blotting  time 
lengths. Changing the biochemical sample preparation we went back to the optimisation 
of  grid  preparation  and  fine  tuned  the  conditions  for  all  biochemically  divergent 
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samples. The typical protein concentration used in amphipol or in detergent was around 
10 mg/mL  and  about  3.5 mg/mL,  respectively.  Samples  were  deposited  on  the 
glow-discharged carbon grids and frozen by FEI Vitrobot  in liquid ethane.  Samples 
were stored under liquid nitrogen until being imaged. Imaging was completed either at 
our institute on the EM platform using Tecnai G2 Polara cryo-transmission EM with a 
300 keV field emission gun (FEG) equipped with a K2 Gatan camera, or in the C-CINA 
scientific  group in Basel  on the KRIOS cryo-TEM with a  80-300 keV FEG, Gatan 
Quantum-LS Energy Filter  (GIF) with a  Gatan K2 Summit  direct  electron  detector. 
Particle  picking  was  carried  out  using  Dr.  Kai  Zhang's  Gautomatch  and  the  data 
treatment was done using Relion software (Scheres, 2012). 
5.2 Electron microscopy - results 
The Cys-loop receptors  are  relatively  good candidates  to  be studied by cryo-EM 
because  of  their  size,  their  five-fold  symmetry  and  the  pre-existence  of  models 
(structures solved by X-ray crystallography). The first structure of a Cys-loop receptor 
ever solved was done by cryo-EM and it  was the structure of the nAChR from the 
electric  organ of  the  Torpedo fish  (Miyazawa et  al.,  2003).  At  the  time  we started 
working on the 5-HT3 project, cryo-EM had already been successfully applied to the 
GlyR  (Du  et  al.,  2015),  providing  insights  into  the  open,  closed  and  desensitised 
structures of this receptor.
 In  my hands,  the  X-ray  crystallization  trials  did  not  lead  to  structures  of  other 
conformational states in addition to that already known. Encouraged by the structure of 
TPRV1, a membrane protein,  whose structure was solved at  3.4 Å resolution using 
cryo-EM (Cao et al., 2013; Liao et al., 2013), we decided to use electron microscopy as 
a complementary method (and as time passed by, as our main structural method).
5.2.1 Initial trials and optimisation
In  our  early  microscopic  trials,  a  few  years  back,  we  used  the  5-HT3  receptor 
solubilised in amphipol. Our/the naive rationale was of a dual nature: the pioneering 
study of TRPV1 had proven the usefulness of amphipols in structural studies (finally), 
and microscopists  advised us to avoid the presence of detergent  during the freezing 
process. We adapted the exchange of detergent for amphipol as described in section 
3.1.5.2.  We  could  obtain  a  homogeneous  pentameric  receptor  after  size-exclusion 
chromatography (Fig. 25).
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Apart  from  this  change  in  tensio-active,  we  first  kept  the  protein  preparation 
procedure  similar  to  that  for  the  crystallographic  sample,  reasoning  that  if  it  could 
crystallise, the protein was of good quality. Thus we used receptor deglycosylated by 
PNGase F and partially digested by trypsin leading to the removal of the Strep-tag and 
of the unstructured intracellular region. Negative stain microscopy in the presence of 
VHH15 nanobodies yielded good-looking micrographs, with side and top orientations 
of proteins, and almost no aggregation (Fig. 26A) Unexpectedly, when we proceeded to 
cryo-EM, we observed aggregation  of  the  entire  sample  caused  by the  nanobodies, 
making it impossible to pick single particles (Fig. 26B). The first lesson learnt was thus 
that a good quality negative stain does not necessarily predict the quality of cryo-EM 
micrographs. Thus we decided to optimise the conditions directly by cryo-EM.
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Early  trials  with  the  receptor  in  amphipol  without  nanobody  present  resulted  in 
micrographs containing mostly one orientation of receptors: top views  (Fig.  27A). In 
addition, it  seemed  that  we had an  aggregation  problem,  shown by the  presence  of 
‘darker’ top views with higher contrast and ‘prolonged’ side views  (Fig.  27B), which 
we hypothesised were head-to-head or head-to-tail dimers.
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We screened different surfactants to solve the orientation and aggregation problems. 
We tested the more polar amphipol version A8-75 and observed greater aggregation 
while the orientation problem persisted (Fig. 28).
As fluorinated detergents (F-TAC) had been used to rescue anisotropic orientations 
of membrane proteins on EM grids, we tested the effect of the addition of F-TAC.  The 
addition of 0.2% F-TAC increased the proportion of side views of the receptor. Because 
0.2% roughly correspond to the concentration required to saturate the air/water interface 
in  a grid hole,  one hypothesis  is  that  F-TAC impact  orientation  via  surface  tension 
modification, and not via interaction with the protein or amphipols.  A side effect of the 
addition of F-TAC was that fewer particles were present in the holes. We tested grids 
with a 2-5 nm layer of carbon on top of the holes to increase the number of particles, but 
this resulted in completely crowded unusable micrographs. We were also concerned that 
the carbon layer might preclude the acquisition of high-resolution data and decided to 
instead make changes to the protein concentration. Compensating the lower density of 
receptor  by  an  increased  starting  concentration  (up  to  ~20 mg/mL),  we collected  a 
dataset with this  sample (5-HT3R-Apol-F-TAC) on the G2 Polara cryo-transmission 
EM with  a  300 keV FEG equipped with  a  K2 Gatan  camera  but  it  yielded only a 
reconstruction  of  limited  resolution,  at  about  8  Å.  We  were  concerned  that 
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conformational  flexibility  of  the  receptor  might  prevent  us  from  reaching  a  better 
resolution and we thus collected a second dataset, using a receptor inhibited with 1 mM 
granisetron. The dataset (5-HT3R-Apol-F-TAC-granisetron) was collected on the Titan 
Krios microscope in the Center for Cellular Imaging and NanoAnalytics (C-CINA) in 
Basel. From 421 micrographs, ~125k particles were picked using the low-filtered model 
of  the  crystallographic  structure.  After  several  rounds of  2D classification,  the  best 
looking classes were put together and ~50k particles were used for 3D classification. 
The best class was further refined, trying the application of different masks, and the 
final resolution was ~7 Å (Fig. 29).
One of the parameters, which influences the quality of the data collected is the ice 
thickness.  In  our  case,  the  ice  layer  was  probably  too  thick  (as  evidenced  by  the 
difficulty of seeing side views on raw images) to obtain the atomic resolution of the 
receptor.  Apart  from the  nature  of  the  particles  themselves,  the  composition  of  the 
buffer composition also influences ice thickness. The salt concentration, together with 
the type  of  tensio-active  molecule  used,  can be  crucial.  We thus  decreased the  salt 
concentration by a factor two but were limited by the relatively high concentration of 
F-TAC (0.2 %).
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 We therefore took a step back and returned to the testing of surfactants, focusing on 
detergents at this  time. Specifically,  we tried 0.05% DDM, 0.1% MNG3 and 0.01% 
C12E9.  When  using  DDM  or  MNG3,  the  receptor  was  purified  in  C12E9 and  we 
exchanged detergents during the final SEC. According to the SEC profiles, the receptor 
was perfectly homogenous in the presence of all detergents. Although both alternative 
detergents, DDM and MNG3, seemed to at least partially solve the orientation problem, 
they caused significant aggregation of the receptor (Fig. 30). 
In the end, the detergent C12E9 was thus shown to be the best choice. It enabled the 
observation  of  multiple  orientations  of  protein  on  the  grid  and  we  solved  the 
aggregation  problem,  which  occurred  during  the  freezing  step,  by  omission  of  the 
limited  digestion (using trypsin) step,  which was routinely  used for  crystallographic 
studies. Additionally,  we retained the disordered intracellular domain of the protein in 
the hope that its presence will prevent aggregation. To mimic the natural conditions as 
closely as possible, we used lipid additives (0.01% phosphatidic acid, 0.01% cholesterol 
hemisuccinate, 0.01% brain phosphatidylcholine,  Avanti Polar lipids).  After testing a 
range of  grids,  we decided to  use  the  Cu-Rh grids,  which  resulted  in  good sample 
quality with the required amount and distribution of particles (Fig. 31). These optimised 
conditions were a good starting point for performing structural studies. 
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5.2.2 The gating mechanism of the m5-HT3RA (enclosed publication)
In the last decade, from the appearance of the first ELIC structure (and even before) 
until  today,  huge  efforts  have  been  made  to  elucidate  the  gating  mechanism(s)  of 
Cys-loop receptors. The “steady state” structure-to-function interpretation remains the 
only method available for this purpose. To date, there are only few receptors whose 
structures  have  been  solved  in  multiple  conformational  states,  which  enables  us  to 
understand their complex gating mechanism. Specifically, these are the structures of the 
WT  GLIC  receptor,  the  GluCl  receptor,  the  engineered  GlyR  structures  and  the 
m5-HT3R structures published in parallel. Here I present our recently published data on 
the 5-HT3R. Four structurally distinct states of 5-HT3RA provide, for the first time, 
insights into the gating mechanism of the cation-selective pLGIC. To get the most out 
of the structures obtained, substituted cysteine accessibility mutagenesis (SCAM) and 
voltage-clamp fluorometry (VCF) were performed to identify the residues lining the 
channel and involved in local conformational changes. Moreover, in collaboration with 
F. Dehez and C. Chipot (CNRS, Nancy, France), we performed molecular dynamics 
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simulation studies to further characterise the ion permeation of the channel. Combining 
the structural and functional studies, we propose a functional interpretation of all of the 
four  structures  obtained,  widening  our  knowledge  of  the  gating  mechanism  (see 
enclosed publication that follows (pages 77 – 98) ).
For the sake of completeness I would like to note that the 5-HT3RA open pore and 
agonist-activated  closed  pore  structures  solved  by  cryo-EM  were  published 
independently  by  Basak  and  co-workers  (Basak  et  al.,  2018b) and  the  structural 
comparison follows the enclosed publication with our results and can be found in the 
section 5.3.
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5.3 Electron microscopy - discussion
 
pLGICs are  prominent  pharmacological  targets,  which  are  studied  intensively,  as 
illustrated by the number of structures solved during the last couple of years. However, 
these structures raise new questions and the detailed functional mechanism still remains 
shrouded by mystery. A comparison of the gating mechanism of 5-HT3RA with the 
mechanism  elucidated  for  the  other  pLGICs  (GluCl,  GLIC  and  GlyR)  is  already 
discussed in our paper (e.g Extended Data Figures 6 and 8). Thus, in this section, I will 
focus on the direct comparison of the 5-HT3RA structures obtained by our group and 
independently  by  the  group  of  Chakrapani,  highlighting  the  main  similarities  and 
proposing reasons for potential differences. 
In the following text I will keep the nomenclature of structures identical to that used 
in the original publications. To make it easier for the reader to become oriented in the 
nomenclature, I will also add the assigned functional state in brackets. 
The  mouse  5-HT3RA  structures  solved  by  cryo-EM  were  assigned  to  multiple 
physiological states, with various levels of confidence in the assignments. There is one 
apo resting state (Basak et al., 2018a), one inhibited state (T) (Polovinkin et al., 2018), 
one potentially pre-activated state plus one structurally closely related state (I1 and I2) 
(Polovinkin et al., 2018), a open pore State 1 structure (Basak et al., 2018a) speculated 
to be non-conducting intermediate or a desensitized state, and two independent open 
pore structures (State  2 and F respectively)  (Basak et  al.,  2018b; Polovinkin  et  al.,  
2018). 
The assignment of the function is indeed more ambiguous for the receptors in the 
intermediate states where the ECD and ECD-TMD structures resemble the open state 
but  where  the  pore  remains  closed.  A  structural  comparison  of  the 
intermediate/desensitised structures shows that the I2 state resembles the independently 
obtained  State  1  (agonist-bound  non-conducting)  to  a  greater  degree,  with  a 
root-mean-square deviation (RMSD) of 1.1 Å, than the I1 state (pre-active state), with 
an RMSD of 1.6 Å (Fig. 32). Drawing conclusions from the RMSD comparison of the 
two independently obtained structures using different data processing and reaching only 
limited resolution is tricky. We can speculate that they might be very closely related, but 
regarding  the  RMSD  differences  among  the  structures  of  receptors  from  different 
families (e.g. comparison of the m-5HT3R to the GABAA subunit with the RMSD of 
1.8 Å data shown in the enclosed publication (Extended data Fig 6., page 92) the option 
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that they represent distinct physiological states should not be neglected .
Unexpectedly, the biggest surprise comes from the comparison of the two open pore 
states:  the  F  state  and  State  2.  Unfortunately,  the  electron  density  maps  are  of 
comparable poor resolution at the level of the ICD in both cases, likely illustrating the 
ICD flexibility. In contrast to our competitors, we found the building of a structure into 
this part of the electron density map tricky and thus residues 311-425 were not built in 
the F state structure. For the purposes of overall structural alignment we use only the 
shortened  version  of  the  State  2  structure  cut-down  to  correspond  to  the  residues 
resolved in  the  F state.  The overall  structural  alignment,  with an  RMSD of  1.9  Å, 
indicates  significant  differences.  Interestingly,  almost  the  same  RMSD  (2.0  Å)  is 
observed between the open state F and the inhibited closed state T. Superimposition of 
the  ECDs  only  shows  that  the  conformation  of  the  F  state  and  of  state  2  closely 
resemble each other with an RMSD of 1.1 Å.
Having a closer look at the binding site, the orientation of the serotonin is the same in 
both  structures,  making  cation-π interaction  with  the  W156  (Fig.  33).  The  inward 
motion of loop C in State 2 seems to be slightly less pronounced compared with the 
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F state when an alignment of the ECD is performed. Even though the relative distance 
(displacement) between the C loops of the apo and the open states solved by Basak et al. 
are similar to those of the inhibited state T and the open state F it seems that loop C 
stays further from loop G of the following subunit. It is difficult to judge the possible 
interaction between residues D202 and R65 in State 2 because of the poor density of the 
aspartate and the generally low resolution in this region. 
The  poorly  defined  electron  density  map  makes  a  more  detailed  comparison 
impossible also around the conserved Cys-loop region and in close proximity of R218 
(important structural features triggering the gating mechanism). Thus it is not possible 
to draw any conclusions from the flipped side chain of W187 in the State 2 structure 
compared to all other structures of the receptor solved both by ourselves and by our 
competitors.
The most striking difference is  a different arrangement of the M2 membrane helices, 
forming the pore, and of their immediate environment, which can be documented by an 
RMSD of 3.3 Å for the TMD region. Isolated TMD monomers superimpose with an 
RMSD of 2.1 Å, indicating that the subunit/subunit arrangement accounts for a large 
part of the differences between the F state and State 2. Accordingly, the interface areas 
in the TMD, measured using PISA, differ significantly, with ~1100 Å2 buried for the F 
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state and only ~750 Å2 for State 2. Comparing the pores, the one of State 2 is generally 
wider than the one of the F state.  This difference is due to the positions of the M2 
helices (Fig. 34). The helices start at about the same position on the intracellular site but 
then they diverge. This results in the ion pathways narrowing at different heights. 
Whereas the F state is largely open at the L9' (L260) activation gate, State 2, even 
though it is widely open, is actually narrowest at the level of this residue  (Fig.  35). 
Compared to the F state, State 2 is significantly wider at the intracellular side of the 
transmembrane pore creating the vestibule. The pore radius of State 2 resembles that of 
the GlyR receptor solved by cryo-EM in the presence of glycine (open structure). This 
widely open pore conformation has brought some controversy  (Gonzalez-Gutierrez et  
al., 2017) because the other open pore structures of pLGIC solved to date are narrower 
at the intracellular side. The structural studies of the mutated GLIC receptor together 
with  molecular  dynamics  and  electrophysiology  studies  further  support  the 
physiological relevance of the narrower open channel structures (Gonzalez-Gutierrez et  
al., 2017).
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Additionally, State 2 represents a less compact transmembrane helix bundle compared 
to the F state. The total volume of the State 2 TMD corresponds to 92.17 kÅ3 (void 
27.81 kÅ3; VDW 64.36 kÅ3) with a protein density of 0.698. The F state TMD total 
volume is 89.03 kÅ3 (void 26.29 kÅ3; VDW 62.73 kÅ3) with a protein density of 0.705. 
All data were calculated by ProteinVolume v1.3 (Chen and Makhatadze, 2015). 
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 Another striking difference between the State 2 structure compared with the other 
conformational states of the receptor is the movement of the MX helix (Fig. 36A). This 
peripheral helix located on the intracellular side is in contact with the membrane in the 
structures  of  all  the other  states  but  is  immersed into  the  membrane  in  the State  2 
structure. This movement is in agreement with the F state that is seen on the alignment 
of the electron density maps of the F state and the I1 state (Fig. 36B).
The  C-terminal  end  of  the  MX  helix  moves  ~10  Å  along  the  normal  to  the 
membrane. Examples of helices that can enter the membrane exist (Entova et al., 2018), 
and this motion might be part of the operation mechanism of the receptor. It might also 
be caused by the detergent environment.
The  differences  between  those  two  open  structures  raise  questions  about  their 
assignment to a physiological state. Multiple factors should be kept in mind. The F state 
and State 2 could potentially correspond to two different conformational states of the 
open receptor. The opening of the channel is a complex process complicated by the 
cooperativity of agonists acting at 5 orthosteric binding sites. The existence of multiple 
open forms has already been proposed for pLGIC (Keramidas and Lynch, 2012) and the 
concept  was  proven  to  be  true  for  the  single-channel  study  of  the  ELIC  receptor 
(Marabelli et al., 2015) and for 5-HT3R (Corradi et al., 2009). When comparing the 
two  structures  solved  independently,  it  is  thus  extremely  important  to  consider  the 
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conditions under which they were obtained.
Therefore,  the  differences  between  the  two  open  structures  might  be  for 
physiological  reasons  (two  distinct  open  states  may  actually  exist)  or  due  to  the 
experimental conditions used. Firstly, the F state structure was solved in the presence of 
calcium cations which are known to affect the receptor conductivity. Secondly, pLGIC 
are known to be sensitive to their lipidic environment and here we are comparing a 
structure solved in the detergent C12E9 with added lipids (CHS, PA and PC) in the case 
of the F state and a structure solved in the presence of the same detergent  and the 
addition  of  fluorinated  Fos-choline  8  for  State  2.  Generally,  the  non-fluorinated 
fos-choline detergents are usually efficient in protein solubilisation but they should be 
used with caution because they might have destabilising and denaturing effect on certain 
proteins (Chipot et al., 2018). In addition the fluorinated detergents might complicate 
interpretations since it was shown that they not only interact with ryanodine receptors 
but also it influences the conformational state of the protein (stabilisation of the closed 
conformation by the fluorinated  octyl  maltoside even after  the application of strong 
agonist) through an unknown mechanism (Willegems and Efremov, 2018).
Last  but  not  least,  there  is  an  option  that  one  of  the  structures  is  too  far  from 
biologically existing physiological state, and the result is an artefact.
For a long time, using detergents was the only way to extract membrane proteins 
from the lipid-bilayer (now, the recently developed SAM/DIBMA copolymers forming 
“native nanodiscs” may provide an alternative (Dörr et al., 2014; Oluwole et al., 2017)). 
Even though the detergent micelles do not reproduce the hallmarks of the lipid-bilayer 
environment, they remain the traditional choice for protein solubilisation, stabilisation 
in solution and thus also for structural studies.. Here I would like to sum up the effect of 
lipids on the pLGICs and how they might influence the structures (and not only those 
obtained  by  cryo-EM).  The  effect  of  amphipathic  molecules,  namely  lipids  and 
detergents, on the TMD of nAChRs was discussed in section 1.5.2.3 (Fernández Nievas 
et al., 2008) and the effect of different detergents and lipid additives on the purified 
5-HT3R was shown in section 4.2.1.3 and at the end of this section. Interestingly, the 
5-HT3R contains the sphingolipid binding motif at the extracellular part of the M1 helix 
(Björkholm et al., 2014). But more generally, amphipathic molecules can have a great 
impact on the structure and/or function of pLGIC. They interact with the receptors in 
the allosteric binding site located in the upper and lower part of their TMD. Some lipids, 
included as additives or even being co-purified, were resolved in the pLGIC structures, 
suggesting tight interactions with the transmembrane helices (Basak et al., 2017, 2018a;  
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Bocquet et al., 2008; Chen et al., 2018) and suggesting possible regions of the receptor 
responsible for the lipid-driven modulation.  In addition,  mutagenesis  of the interface 
between the outermost M4 helix and helices M1/M3 separated the pLGIC superfamily 
into two groups based on the compactness and tightness of this lipid-exposed region. 
GLIC, together with GlyR, the GABA receptor and GluCl, have extensive networks of 
interacting aromatic residues that form a densely packed M4-M1/M3 interface along the 
entire length of the M4 helix. In contrast, ELIC, the nAChR and the 5-HT3RA have 
fewer interactions in this region (Therien and Baenziger, 2017). The Ala mutations of 
the aliphatic residues have  have moderate or no effect as well as mutations of polar 
residues  at  the  M4  - M1/M3  interface  with  exception  of  the  M4  - M1  cation-π 
interactions  which mutated abolish the ELIC functioning.  Even though the aromatic 
side chain residues interactions are predominant in both, Ala mutations of single or both 
aromatic residues impair the GLIC whereas it has a little effect on the ELIC function. 
Those two groups, represented either by GLIC or by ELIC, should be potentially less or 
more  prone  to  be  influenced  by  changes  in  the  surrounding  lipid  environment, 
respectively.  Additionally  the  group  to  which  the  5-HT3A  belongs  might  undergo 
conformational changes more readily due to the weaker interactions. 
The  distorted  GABA  structures,  imaged  in  detergent,  show  the  gamma  subunit 
collapsing  into  the  pore  and  assymetric  organisation  of  subunits  the  two  different 
serotonin receptor structures in the open pore conformation could point to amphipathic 
molecules as a common denominator. But how does one choose detergents and lipids? 
Quite often the protein stability is measured prior to structural determination in order to 
get  the  most  stable  sample  possible.  This  method,  popularised  by  the  Gouaux  lab 
(Gouaux et al., 2012), has been used for GluCl, the GABA structure, and was probably 
used even for other structures. However, the generally intuitive idea that conditions, 
which result in the most thermostable proteins equal conditions where receptors are in a 
stable physiological state, may not be true in all cases. The artificial lateral  pressure 
potentially created by the amphipathic molecules may result in non physiological tighter 
packing of the membrane domain helices, thus increasing the intramolecular interaction 
surface. Specifically, in the presence of an increased level of artificial interactions, the 
amount of energy needed to break them is higher. Finally, the higher thermal stability of 
proteins in amphipathic additives might reflect stronger non-native interactions and its 
maximisation  might  lead  to  false  positive  results.  We tested  the  effect  of  different 
detergents on the protein stability and we can conclude that the detergents differ in their  
ability to stabilise the 5-HT3RA. Furthermore, in our hands the 5-HT3RA manifests the 
same thermal stability after the addition of lipid master mix (PA, CHS and brain PC; 
concentrations  corresponding  to  our  cryo-EM  experiments)  as  it  does  in  C12E9 
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(Fig. 38A)  (measured  by  NanoTemper's  Prometheus,  experiment  performed  in 
agreement with the detergent screen described in 4.1.3). Interestingly, the addition of 
CHS during solubilisation by C12E9 affects the thermostability to a greater extent than 
addition of CHS just prior to measurement Fig. 38B) . 
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6 Conclusion and perspectives
The  objectives  of  my  thesis  were  to  obtain  structure(s)  of  other  conformational 
state(s)  compared to  the 2014 crystal  structure and/or  increase the resolution  of  the 
existing structure of 5-HT3RA (to enable for instance the unambiguous placement of 
ligands).  We have shown that  the  5-HT3RA can form crystals  in  a  broad range of 
conditions (temperature, pH, salts, PEGs) using stabilising nanobodies and Cymal-6 as 
an  additive.  We failed  to  improve the  poor  diffraction  of  these  crystals  with many 
standard  methods  (cryoprotection,  dehydration  of  crystals,  on-plate  measurements). 
Larger changes need to be implemented to improve the crystal quality. We have shown 
that changing the detergent might be critical step and we have selected the detergent 
UDM as a good candidate (section 4.2.1.2).
Starting with no prior experience of electron microscopy, we were able to gradually 
optimise the sample and the imaging conditions. In the end we obtained four structures 
of  different  conformations  of  the  5-HT3RA by cryo-EM, and could assign  them to 
physiological states and propose a gating mechanism for this receptor compatible with 
SCAM and VCF experiments, which was also supported by molecular dynamics. The 
proposed gating mechanism shares some common features (quaternary reorganisation of 
the ECD, local movements in the ECD-TMD and the upper TMD region, general twist) 
and  possesses  some  distinct  ones  compared  to  the  mechanisms  inferred  for  other 
pLGICs (in contrast to GLIC and GluCl the 5-HT3A and GlyR don't undergo the ECD 
un-blooming reorganisation, the pore radius of the 5-HT3RA lies in between those of 
the wider  GlyR and the tighter  GLIC pore,  specific  M4 sliding)  (Polovinkin  et  al.,  
2018). Finally, we compared our structures with the structures obtained by Chakrapani's 
group and noted a puzzling difference in the open pore structures (section 5.3). 
The  challenging  dream  to  elucidate  the  gating  mechanism  of  the  pLGICs  is 
becoming more and more realistic but together with a better understanding of the gating 
more  questions  are  raised.  Even  though  the  pLGIC  share  some  highly  conserved 
sequences,  specifically  their  overall  architecture  and  general  gating  apparatus,  their 
actual  mechanism seems to differ.  To generalise  based on what we know about the 
gating mechanism of  one family  of receptors  is  no longer  possible  and conclusions 
generalised to the entire  superfamily should be made with caution. 
Structural studies like ours raise a lot of questions about their physiological relevance 
(as exemplified by a significant portion of the reviewer's comments to our paper) and 
they  are  sometimes  still  received  with  scepticism.  The  purified  protein  stability, 
biochemical environment and physical properties used in those studies are indeed not 
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ideal  mimics  of physiological  conditions.  Yet it  is  undeniable that  structural  studies 
performed  after  careful  biochemistry  deepen  our  understanding  of  how  membrane 
proteins function. 
A potentially controversial point is the assignment of a structure to a functional state. 
This assignment can be non-straightforward for all mechanistic proteins, which undergo 
certain conformational changes during their action. For pLGICs some classical criteria 
have  emerged  from the  accumulated  literature  and are  used  to  guide  the  functional 
labeling of structures: the position of the loop C, the overall channel radius, the width of 
the channel at the 9' position, the constriction at the selectivity filters, etc. Fortunately, 
the field is moving forward with more nuanced definitions of what is a closed/open 
pore, taking advantage of molecular dynamics. Not every structure to be solved can be 
easily categorised into the simple three-state model with a resting closed pore, an active 
open pore  and  a  desensitised  closed  pore  state.  The  structures  of  different  pLGICs 
elucidated under a variety of conditions (presence/absence of ligand; use of stabilising 
nanobodies/Fabs; use of detergents, amphipol or nanodiscs) instead correspond to other 
classes (most of them known also from electrophysiology) like the apo-resting state, the 
ligand-bound resting state, or the ligand-bound pre-active state. 
In  summary,  it  is  clear  that  the  pLGIC field  is  missing  time-resolved  structural 
studies,  ideally  performed  under  native  conditions.  Amongst  the  methods  currently 
available, this may be achievable using X-ray free electron laser (XFEL) measurements. 
For  this  purpose  the  development  of  photo-activatable  ligands  and  easy  growth  of 
nanocrystal would need to be accomplished first. Both of those aspects, together with 
very limited availability of XFEL hardware, lower the probability of success using this 
method.
Considering the “available” methods and instruments, further structural studies by 
cryo-EM  are  of  great  interest.  The  potential  influence  of  detergent,  F-TAC  and 
amphipol on 5-HT3RA could be deduced from structures solved in “membrane-like” 
conditions, using nanodiscs (or other type of discs). This will require the optimisation of 
the  protocol  for  protein  incorporation  into  the  nanodiscs  and  possibly  even  require 
further  rounds  of  grid  preparation  optimisation.  The  structures  of  the  receptor  in 
complex  with  an  allosterically  bound  ligand  (relatively  straightforward),  of  the 
heteropentamer  (requirement  for  sufficient  amounts  of  the  purified  heteropentamer, 
which is more fragile compared to homopentamers) or of the protein with/without ICD 
in combination with/without the use of calcium in the presence of serotonin (in theory, 
only the structure without the ICD in the presence of calcium and serotonin is needed to 
compare with the structure already solved) might bring some insights into the protein 
pharmacology, functioning and assembly.
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8 Supplementary data
Table 1 | The summary of the pLGIC structures solved by different methods.
This table was generated using data and online software provided by rcsb.org (the PDB; Protein Data 
Bank). Data generated on 12 August, 2019.
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